image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
c3bebfcb3faeaa222e62fb294fefc2e8cdbb21c1273918639ea5b65ca6e9e84d.png | simple | <table><tr><td>Gene</td><td>Forward primer</td><td>Backward primer</td><td>Size (bp)</td></tr><tr><td>GAPDH</td><td>GGTCGTATTGGGCGCCTGGTC</td><td>TGACGGTGCCATGGAATTTGCCA</td><td>148</td></tr><tr><td>KIFC1</td><td>TCTCTGGGTGGTAGTGCTAAGA</td><td>TAAGTCACTTCCTGTTGGCCTG</td><td>148</td></tr><tr><td>SOX4</td><td>GACCGGGACCT... | <table><tr><td>Gene</td><td>Forward primer</td><td>Backward primer</td><td>Size (bp)</td></tr><tr><td>GAPDH</td><td>GGTCGTATTGGGCGCCTGGTC</td><td>TGACGGTGCCATGGAATTTGCCA</td><td>148</td></tr><tr><td>KIFC1</td><td>TCTCTGGGTGGTAGTGCTAAGA</td><td>TAAGTCACTTCCTGTTGGCCTG</td><td>148</td></tr><tr><td></td><td>GAC</td><td>TGA... | <table><tr><td>SOX4</td><td>CGGGACCTGGATTTTAACT</td><td>ACCAGGTTGGAGATGCT</td><td>3</td></tr><tr><td>PBX2</td><td>AAGTTCCAAGAGGAGGCAAACA</td><td>TCCTGAGAGATTGAAAGAGCCG</td><td>132</td></tr><tr><td>ESRRG</td><td>GCTATCCTGCAGCTGGTAAAGA</td><td>GCTATCCTGCAGCTGGTAAAGA</td><td>133</td></tr><tr><td>KDM5B</td><td>CCCTCAGACACA... |
bbbeb327c6a6d4d78e31f169f0b5473609293e588a65fead99193a73f689b576.png | complex | <table><tr><td>Predictors</td><td>OR</td><td colspan="2">95% CI</td><td><i>p</i>-Value</td><td>Nagelkerke R<sup>2</sup></td></tr><tr><td>Perceived benefits of HSIV:</td><td></td><td colspan="2"></td><td></td><td rowspan="6">0.631</td></tr><tr><td>HSIV can prevent children from catching Influenza</td><td>2.367</td><td c... | <table><tr><td>Predictors</td><td>OR</td><td colspan="2">95% CI</td><td>p-Value</td></tr><tr><td>Perceived benefits of HSIV:</td><td></td><td colspan="2"></td><td></td></tr><tr><td>HSIV can prevent children from catching Influenza</td><td>2.367</td><td colspan="2">(1.272, 4.404)</td><td>0.007</td></tr><tr><td>Perceived... | <table><tr><td>Nagelkerke R2</td></tr><tr><td rowspan="6">0.631</td></tr><tr></tr><tr></tr><tr></tr><tr></tr><tr></tr></table> |
48cf0b821dd67ebe2b979e947ca82e4911daf27845b6836fbb674220a8f8f563.png | simple | <table><tr><td></td><td>Desmopressin (n = 45)</td><td>Control (n = 45)</td><td><i>P</i></td></tr><tr><td>Propofol (mg)</td><td>830 (195)</td><td>780 (177)</td><td>0.2</td></tr><tr><td>Remifentanil (μg)</td><td>1350 (235)</td><td>1785 (260)</td><td><0.001</td></tr><tr><td>Esmolol (mg)</td><td>15 (4.5)</td><td>40... | <table><tr><td></td><td>Desmopressin (n = 45)</td><td>Control (n = 45)</td><td>P</td></tr><tr><td>Propofol (m</td><td></td><td>78</td><td>0</td></tr></table> | <table><tr><td>g)</td><td>830 (195)</td><td>0 (177)</td><td>.2</td></tr><tr><td>Remifentanil (μg)</td><td>1350 (235)</td><td>1785 (260)</td><td><0.001</td></tr><tr><td>Esmolol (mg)</td><td>15 (4.5)</td><td>40 (7.5)</td><td><0.001</td></tr><tr><td>Nicardipine (mg)</td><td>0.25 (0.06)</td><td>0.26 (0.07)</td><td>0.5</td>... |
17c1c9241bd41b345de51d810f334037c6023e538637cfef196515c8c7547c37.png | complex | <table><tr><td rowspan="2">References</td><td colspan="4">SCI model</td><td rowspan="2">Methods</td><td rowspan="2">LncRNA expression changes</td></tr><tr><td>Animal</td><td>Method</td><td>Level</td><td>Sampling</td></tr><tr><td>35</td><td>Adult female SD rats (200–250 g)</td><td>Contusive spinal cord injury usin... | <table><tr><td rowspan="2">References</td><td colspan="4">SCI model</td><td rowspan="2">Methods</td></tr><tr><td>Animal</td><td>Method</td><td>Level</td><td>Sampling</td></tr><tr><td>35</td><td>Adult female SD rats (200–250 g)</td><td>Contusive spinal cord injury using an NYU impactor (10 g, 12.5 mm)</td><td>T10</td><t... | <table><tr><td rowspan="2">LncRNA expression changes</td></tr><tr></tr><tr><td>1 dpo: 1 down, 6 up4 dpo: 5 down, 2 up7 dpo: 5 down, 2 up</td></tr><tr><td>1 dpo: 181 down, 164 up3 dpo: 290 down, 212 up1 wpo: 565 down, 326 up3 wpo: 40 down, 141 up</td></tr><tr><td>1mpo: 17 down, 120 up3mpo: 77 down, 162 up6mpo: 54 down, ... |
a408b6c3a8dbd3a022d59e31952258b73b2fe0c509f8a0fe47dce713f518ef8f.png | complex | <table><tr><td>Characteristics of preliminary categories</td><td>Final categories</td><td colspan="2">1999/2000</td><td colspan="2">2005</td><td colspan="2">2010</td></tr><tr><td></td><td></td><td><i>n</i></td><td>%</td><td><i>n</i></td><td>%</td><td><i>n</i></td><td>%</td></tr><tr><td>Permanent work</td><td rowspan="2... | <table><tr><td>Characteristics of preliminary categories</td><td>Final categories</td><td colspan="2">1999/2000</td><td colspan="2">2005</td><td colspan="2">2010</td></tr><tr><td></td><td></td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Permanent work</td><td rowspan="2">Non-precarious empl... | <table><tr><td>All others with contingent work AND/OR moderate to high self-rated risk of future unemployment AND/OR previous unemployment</td><td>Precarious employment (PE)</td><td>416</td><td>36.6</td><td>306</td><td>26.9</td><td>207</td><td>18.2</td></tr><tr><td>Unemployed</td><td>Precarious employment (PE)</td><td>... |
406c0171886c30f3fc19453aabb817aaa4790e744fe47da6cf5fb8ba13d61aef.png | complex | <table><tr><td></td><td colspan="2">Did not participate Patella lead level</td><td colspan="2">Participated Patella lead level</td></tr><tr><td>Characteristic</td><td>Low (<i>n</i> = 90)</td><td>High (<i>n</i> = 103)</td><td>Low (<i>n</i> = 15)</td><td>High (<i>n</i> = 16)</td></tr><tr><td>Mean age in years ± SD a... | <table><tr><td></td><td>Did not participate Patella lead level</td></tr><tr><td>Characteristic</td><td>Low (n = 90)</td></tr><tr><td>Mean age in years ± SD at MRSa</td><td>73.0 ± 6.2</td></tr><tr><td>Mean years ± SD of education</td><td>15.3 ± 2.5</td></tr><tr><td>Mean ± SD serum creatinine (mg/dL)</td><td>1.1 ± 0.5</t... | <table><tr><td>Did not participate Patella lead level</td><td colspan="2">Participated Patella lead level</td></tr><tr><td>High (n = 103)</td><td>Low (n = 15)</td><td>High (n = 16)</td></tr><tr><td>78.0 ± 5.9</td><td>73.2 ± 4.7</td><td>80.7 ± 6.1</td></tr><tr><td>13.2 ± 2.6</td><td>16.3 ± 3.1</td><td>13.4 ± 2.6</td></t... |
cb183b91b0829d4172441d1e23a57b1dada5c2a87c56880c64c35cea3d8c2b60.png | complex | <table><tr><td colspan="3">Sodium nitrite</td><td colspan="3">Sodium nitrate</td></tr><tr><td>Spiked level (<i>μ</i>g·g<sup>−1</sup>)</td><td>Recovery (%)</td><td>SD</td><td>Spiked level (<i>μ</i>g·g<sup>−1</sup>)</td><td>Recovery (%)</td><td>SD</td></tr><tr><td>50</td><td>96</td><td>13.... | <table><tr><td colspan="3">Sodium nitrite</td><td colspan="3">Sodium nitrate</td></tr><tr><td>Spiked level (μg·g−1)</td><td>Recovery (%)</td><td>SD</td><td>Spiked level (μg·g−1)</td><td>Recovery (%)</td><td>SD</td></tr><tr><td>50</td><td>96</td><td>13.68</td><td>50</td><td>96</td><td>7.13</td></tr><tr><td>100</td><td>1... | <table><tr><td colspan="3">Sodium nitrite</td><td colspan="3">Sodium nitrate</td></tr><tr><td>Spiked level (μg·g−1)</td><td>Recovery (%)</td><td>SD</td><td>Spiked level (μg·g−1)</td><td>Recovery (%)</td><td>SD</td></tr><tr><td>200</td><td>101</td><td>3.19</td><td>200</td><td>98</td><td>6.76</td></tr></table> |
7e2b7326855f54565729ba0de8c5c8c9dcd459881765a54ed56b5d8352aeb6a9.png | simple | <table><tr><td> </td><td>Other</td><td>Division</td><td>FN</td><td>FP</td></tr><tr><td>Other</td><td>935</td><td>69</td><td>66</td><td>85</td></tr><tr><td>Division</td><td>99</td><td>3395</td><td>31</td><td>68</td></tr><tr><td>FN/1:1</td><td>79</td><td>39</td><td>546</td><td>43</td></tr><tr><td>FP</td><td>17</td><td>7<... | <table><tr><td></td><td>Other</td><td>Division</td></tr><tr><td>Other</td><td>935</td><td>69</td></tr><tr><td>Division</td><td>99</td><td>3395</td></tr><tr><td>FN/1:1</td><td>79</td><td>39</td></tr><tr><td>FP</td><td>17</td><td>7</td></tr></table> | <table><tr><td>FN</td><td>FP</td></tr><tr><td>66</td><td>85</td></tr><tr><td>31</td><td>68</td></tr><tr><td>546</td><td>43</td></tr><tr><td>28</td><td>1416</td></tr></table> |
3bd9b587ec89681e754e1aded5e2b057c69130af4eda27b25cf1b6869acc8ade.png | simple | <table><tr><td>Descriptor</td><td>SVM</td><td>unSVM</td><td>Bagging</td><td>unBagging</td><td>asBagging</td><td>PRIFEAB</td></tr><tr><td>BCUT</td><td>98.2(0.1)</td><td>97.9(0.1)</td><td>97.6(0.1)</td><td>97.8(0.1)</td><td>68.3(0.4)</td><td>67.3(0.2)</td></tr><tr><td>CONST</td><td>98.2(0.1)</td><td>98.3(0.1)</td><td>98.... | <table><tr><td>Descriptor</td><td>SVM</td><td>unSVM</td><td>Bagging</td><td>unBagging</td><td>asBagging</td><td>PRIFEAB</td></tr></table> | <table><tr><td>BCUT</td><td>98.2(0.1)</td><td>97.9(0.1)</td><td>97.6(0.1)</td><td>97.8(0.1)</td><td>68.3(0.4)</td><td>67.3(0.2)</td></tr><tr><td>CONST</td><td>98.2(0.1)</td><td>98.3(0.1)</td><td>98.2(0.1)</td><td>98.2(0.1)</td><td>65.3(0.5)</td><td>66.2(0.3)</td></tr><tr><td>PROP</td><td>98.1(0.1)</td><td>97.8(0.1)</td... |
e825d1adfd1a39b72806b3d56f7f74883ac4b5dc8504d935a22fe05d3df95b93.png | simple | <table><tr><td></td><td>N</td><td>n female</td><td>Age range</td></tr><tr><td>Tutor: Medical Doctor</td><td>1</td><td>0</td><td>51</td></tr><tr><td>Tutors: CO/AMO</td><td>3</td><td>0</td><td>41 – 65</td></tr><tr><td>Tutor: Nurse</td><td>1</td><td>1</td><td>35</td></tr><tr><td>Students: First year</td><td>3</td><t... | <table><tr><td></td><td>N</td><td>n female</td><td>Age range</td></tr></table> | <table><tr><td>Tutor: Medical Doctor</td><td>1</td><td>0</td><td>51</td></tr><tr><td>Tutors: CO/AMO</td><td>3</td><td>0</td><td>41 – 65</td></tr><tr><td>Tutor: Nurse</td><td>1</td><td>1</td><td>35</td></tr><tr><td>Students: First year</td><td>3</td><td>1</td><td>19 – 28</td></tr><tr><td>Students: Second year</td><td>3<... |
6cf9fa469df7c9a67d1774890062c59eba16c889a859dba01898192fdc8d2fff.png | simple | <table><tr><td>Predictors</td><td><i>df</i></td><td>AIC<sub>c</sub></td><td>ΔAIC<sub>c</sub></td><td><i>w</i><sub>i</sub></td></tr><tr><td>Δ Latitude of the 80% diversity contour</td><td>3</td><td>−348.31</td><td>0.00</td><td>0.65</td></tr><tr><td>Δ Eastern U.S. winter temperature</td><td>3</td><td... | <table><tr><td>Predictors</td><td>df</td><td>AICc</td><td>ΔAICc</td><td>wi</td></tr><tr><td>Δ Latitude of the 80% diversity contour</td><td>3</td><td>−348.31</td><td>0.00</td><td>0.65</td></tr><tr><td>Δ Eastern U.S. winter temperature</td><td>3</td><td>−345.14</td><td>3.17</td><td>0.13</td></tr></table> | <table><tr><td>Null</td><td>2</td><td>−344.74</td><td>3.57</td><td>0.11</td></tr><tr><td>Global temperature anomaly</td><td>3</td><td>−342.55</td><td>5.76</td><td>0.04</td></tr><tr><td>Northern hemisphere temperature anomaly</td><td>3</td><td>−342.42</td><td>5.88</td><td>0.03</td></tr><tr><td>Eastern U.S. temperature a... |
a17e926f2eb4a969ee51fb8ab7806abb9badc13db713dd7936e1d4dc00d3eef8.png | simple | <table><tr><td>Correction Method</td><td>Mean Error before Correction (mm)</td><td>Mean Error after Correction (mm)</td><td>Standard Deviation before Correction (mm)</td><td>Standard Deviation after Correction (mm)</td></tr><tr><td>Interpolation</td><td>2.737</td><td>0.325</td><td>2.781</td><td>0.549</td></tr><tr><td>F... | <table><tr><td>Correction Method</td><td>Mean Error before Correction (mm)</td><td>Mean Error after Correction (mm)</td><td>Standard Deviation before Correction (mm)</td><td>Standard Deviation after Correction (mm)</td></tr><tr><td>Interpolation</td><td>2.737</td><td>0.325</td><td>2.781</td><td>0.549</td></tr></table> | <table><tr><td>Function (FFT)</td><td>2.737</td><td>0.400</td><td>2.781</td><td>0.581</td></tr></table> |
60fa1e371e87f472a55126faf20aef3c6126a9551e0c08d1cd9c498a47018179.png | complex | <table><tr><td></td><td colspan="3">Test group*</td><td colspan="3">Active control group*</td><td colspan="3">Total</td></tr><tr><td></td><td>N</td><td>Mean</td><td>SD</td><td><i>N</i></td><td>Mean</td><td>SD</td><td><i>N</i></td><td>Mean</td><td>SD</td></tr><tr><td>Usefulness of</td><td></td><td></td><td></td><td></td... | <table><tr><td></td><td colspan="3">Test group*</td><td colspan="3">Active control group*</td><td colspan="3">Total</td></tr><tr><td></td><td>N</td><td>Mean</td><td>SD</td><td>N</td><td>Mean</td><td>SD</td><td>N</td><td>Mean</td><td>SD</td></tr><tr><td>Usefulness of</td><td></td><td></td><td></td><td></td><td></td><td>... | <table><tr><td>faction</td><td>1</td><td>1</td><td>76</td><td>9.5</td><td>7</td><td>5</td><td>9</td></tr></table> |
e6b3e49dd19935c3ed272169619cdc05c96bddde05127dc50718bac0db4d25d8.png | simple | <table><tr><td>Old name*</td><td>New name*</td></tr><tr><td>N.CglI</td><td>H.CglI</td></tr><tr><td>N.NgoAVII</td><td>H.NgoAVII</td></tr></table> | <table><tr><td>Old name*</td><td>New name*</td></tr><tr><td>N.CglI</td><td>H.CglI</td></tr></table> | <table><tr><td>N.NgoAVII</td><td>H.NgoAVII</td></tr></table> |
f62fe39e36a1891dc767cf5d18e83b767b7a7be3c1b1c1aa7681f947e35a20aa.png | simple | <table><tr><td> Index </td><td> SS </td><td> df </td><td> MS </td><td> F </td><td> p </td></tr><tr><td> Pre-tests and post-tests of interaction </td><td> 34.16 </td><td> 1 </td><td> 17.08 </td><td> 0.10 </td><td> 0.900 </td></tr></table> | <table><tr><td>Index</td><td>SS</td><td>df</td><td>MS</td></tr><tr><td>Pre-tests and post-tests of interaction</td><td>34.16</td><td>1</td><td>17.08</td></tr></table> | <table><tr><td>F</td><td>p</td></tr><tr><td>0.10</td><td>0.900</td></tr></table> |
1c40140cfb9e98102459ffab5a1d052eba52b524bfd10e959607fc3cd83857b4.png | simple | <table><tr><td>Anterior wall</td><td> </td></tr><tr><td> TCC</td><td>16,5 μm</td></tr><tr><td> Spectral estimation Burg </td><td>19,5 μm</td></tr><tr><td> Spectral estimation Yule-Walker</td><td>21,3 μm</td></tr><tr><td>Posterior wall</td><td> </td></tr><tr><td> TCC</td><td>16,5 μm</td></tr><tr><td>... | <table><tr><td>Anterior wall</td><td></td></tr><tr><td>TCC</td><td>16,5 μm</td></tr><tr><td>Spectral estimation Burg</td><td>19,5 μm</td></tr><tr><td>Spectral estimation Yule-Walker</td><td>21,3 μm</td></tr><tr><td>Posterior wall</td><td></td></tr><tr><td>TCC</td><td>16,5 μm</td></tr></table> | <table><tr><td>Anterior wall</td><td></td></tr><tr><td>Spectral estimation Burg</td><td>22,0 μm</td></tr><tr><td>Spectral estimation Yule-Walker</td><td>17,0 μm</td></tr></table> |
01efa08cdf70280384b9f015c205e9f71e6c6b4f4fdbd9a157b45d424846263e.png | complex | <table><tr><td> </td><td> </td><td> </td><td><i>N</i> (%)</td></tr><tr><td rowspan="2">Age, years</td><td>Median</td><td>63.0</td><td></td></tr><tr><td>Range</td><td>33–81</td><td></td></tr><tr><td rowspan="2">Sex</td><td>Male</td><td></td><td>31 (70.5%)</td></tr><tr><td>Female</td><td></td><td>13 (29.5%)</td></t... | <table><tr><td></td><td></td><td></td><td>N (%)</td></tr><tr><td rowspan="2">Age, years</td><td>Median</td><td>63.0</td><td></td></tr><tr><td>Range</td><td>33–81</td><td></td></tr><tr><td rowspan="2">S</td><td>Male</td><td></td><td>31 (70.5%)</td></tr><tr><td>F</td><td></td><td>1</td></tr></table> | <table><tr><td></td><td></td><td></td><td>N (%)</td></tr><tr><td>ex</td><td>emale</td><td></td><td>3 (29.5%)</td></tr><tr><td rowspan="3">ECOG performance status</td><td>0</td><td></td><td>24 (54.5%)</td></tr><tr><td>1</td><td></td><td>15 (34.1%)</td></tr><tr><td>2</td><td></td><td>5 (11.4%)</td></tr><tr><td rowspan="3... |
c2d517def650321af709d43bcdc07e838d2804f2e7f22f453d2fcd77c45f992c.png | complex | <table><tr><td rowspan="2">Host Strains with <i>rpoB</i> Alleles</td><td colspan="2">Cell Viability (±SE) [% Plasmid Loss] Per Growth of Transformant at 42 °C</td></tr><tr><td>[cII] <sup>a</sup></td><td>[cII-oop-pO94] <sup>b</sup></td></tr><tr><td>594 <sup>c</sup></td><td><0.001 (0.001) [100]</td><td>0.08 ... | <table><tr><td rowspan="2">Host Strains with rpoB Alleles</td><td colspan="2">Cell Viability (±SE) [% Plasmid Loss] Per Growth of Transformant at 42 °C</td></tr><tr><td>[cII] a</td><td>[cII-oop-pO94] b</td></tr><tr><td>594 c</td><td><0.001 (0.001) [100]</td><td>0.08 (0.03) [0]</td></tr><tr><td>594 rpoB B1</td><td><0.00... | <table><tr><td>594 rpoB C4</td><td>0.003 (0.010) [0]</td><td>0.07 (<0.0001) [0]</td></tr><tr><td>594 rpoB C10</td><td>0.004 (0.001) [100]</td><td>1.00 (0.01) [0]</td></tr><tr><td>594 rpoB D2</td><td>0.38 (<0.0001) [0]</td><td>0.10 (<0.0001) [81]</td></tr><tr><td>594 rpoB D6</td><td>0.02 (0.01) [6]</td><td>0.03 (0.01) [... |
4bc97d0f32b5cbc58a598625d14664a515270452cfc158dcce2ee2078899049b.png | complex | <table><tr><td>Category of intervention</td><td>Effective interventions for nurse retention</td><td>Strength of evidence<sup>*</sup></td></tr><tr><td rowspan="4">A. Education and continuous professional development interventions</td><td>-Recruitment from, and training in, rural areas</td><td>Moderate [26]<sup>#</sup></... | <table><tr><td>Category of intervention</td><td>Effective interventions for nurse retention</td><td>Strength of evidence*</td></tr><tr><td rowspan="4">A. Education and continuous professional development interventions</td><td>-Recruitment from, and training in, rural areas</td><td>Moderate [26]#</td></tr><tr><td>-Targe... | <table><tr><td rowspan="3">B. Regulatory interventions</td><td>-Increased opportunities for recruitment to civil service</td><td rowspan="3">Low [25]#</td></tr><tr><td>-Recognizing overseas qualifications</td></tr><tr><td>-Producing different types of health workers</td></tr><tr><td rowspan="2">C. Financial incentives<... |
f80070c9c2ac2cac06a9f4cb7910b68ec2130615aa2e8f183c64f6cbe70c8b16.png | complex | <table><tr><td rowspan="2">Brain region</td><td colspan="3">MR image</td><td colspan="3">PET image</td></tr><tr><td>Volume(mm<sup>3</sup>)</td><td>Mean voxel Activity concentration<sup>a</sup> (kBq·mL<sup>−1</sup>)</td><td>Mean ROI activity(Bq)</td><td>Volume(mm<sup>3</sup>)</td><td>Mean voxelActivity concen... | <table><tr><td rowspan="2">Brain region</td><td>MR image</td></tr><tr><td>Volume(mm3)</td></tr><tr><td>Left striatum</td><td>16.4</td></tr><tr><td>Right striatum</td><td>15.1</td></tr><tr><td>Hippocampus</td><td>26.4</td></tr><tr><td>Frontal cortex</td><td>46.1</td></tr><tr><td>Posterior cortex</td><td>49.6</td></tr><t... | <table><tr><td colspan="2">MR image</td><td colspan="3">PET image</td></tr><tr><td>Mean voxel Activity concentrationa (kBq·mL−1)</td><td>Mean ROI activity(Bq)</td><td>Volume(mm3)</td><td>Mean voxelActivity concentrationb (kBq·mL−1)</td><td>Mean ROIactivity(Bq)</td></tr><tr><td>0.50</td><td>8.19</td><td>15.3</td><td>0.5... |
5c35897036baa0d3aee5ee7084740f7215795795287b49ff1fb2c2b1a4c468ce.png | complex | <table><tr><td>Reaction type</td><td colspan="2">All reactions</td><td colspan="2">Reaction following GA<sup>b</sup></td></tr><tr><td> </td><td>N</td><td>% of all reactions<sup>a</sup></td><td>N</td><td>% of reaction types, where reaction followed GA</td></tr><tr><td>Nausea and/or vomiting</td><td>400</td><td>27.5%</td... | <table><tr><td>Reaction type</td><td colspan="2">All reactions</td><td colspan="2">Reaction following GAb</td></tr></table> | <table><tr><td></td><td>N</td><td>% of all reactionsa</td><td>N</td><td>% of reaction types, where reaction followed GA</td></tr><tr><td>Nausea and/or vomiting</td><td>400</td><td>27.5%</td><td>295</td><td>73.8%</td></tr><tr><td>Pruritus</td><td>243</td><td>16.7%</td><td>232</td><td>95.5%</td></tr><tr><td>Constipation<... |
807ae086788ae01bc3a546a8eefdd206953d14182f6d85e4969d1f9d10beed60.png | simple | <table><tr><td>Number of patients</td><td>Disease progression</td><td>Localized</td><td><i>P</i> Value</td></tr><tr><td>Age(Range)</td><td>57.19 (36.85-74.92)</td><td>60.61 (44.38-91.38)</td><td>0.1692</td></tr><tr><td>Median Time to Relapse (years)</td><td>1.59 (0.23-4.91)</td><td></td><td></td></tr><tr><td>Median Fol... | <table><tr><td>Number of patients</td><td>Disease progression</td><td>Localized</td><td>P Value</td></tr><tr><td>Age(Range)</td><td>57.19 (36.85-74.92)</td><td>60.61 (44.38-91.38)</td><td>0.1692</td></tr><tr><td>Median Time to Relapse (years)</td><td>1.59 (0.23-4.91)</td><td></td><td></td></tr><tr><td>Median Followup (... | <table><tr><td>Grade 3-4</td><td>21</td><td>15</td><td>*0.0066</td></tr></table> |
532022de91064e1ba9ed8fab73d56079fd76f1a330ab6d9d4adde35bd8792f99.png | simple | <table><tr><td>Matrix</td><td>Original (μg/kg)</td><td>Spiked (μg/kg)</td><td>Determined (μg/kg)</td><td>Recovery (%)1</td></tr><tr><td>Potato chips</td><td>53.2</td><td>100</td><td>151.2</td><td>98.0 ± 0.8</td></tr><tr><td>Chips (except potato chips)</td><td><LOQ</td><td>100</td><td>97.7</td><td... | <table><tr><td>Matrix</td><td>Original (μg/kg)</td><td>Spiked (μg/kg)</td><td>Determined (μg/kg)</td><td>Recovery (%)1</td></tr><tr><td>Potato chips</td><td>53.2</td><td>100</td><td>151.2</td><td>98.0 ± 0.8</td></tr><tr><td>Chips (except potato chips)</td><td><LOQ</td><td>100</td><td>97.7</td><td>97.7 ± 1.0</td></tr><t... | <table><tr><td>Chocolate products</td><td><LOQ</td><td>100</td><td>96.7</td><td>96.7 ± 3.2</td></tr><tr><td>Breakfast cereals</td><td>9.7</td><td>100</td><td>117.3</td><td>107.6 ± 0.7</td></tr><tr><td>Tea products</td><td>13.3</td><td>100</td><td>107.8</td><td>94.5 ± 0.2</td></tr><tr><td>Seasoned laver</td><td><LOQ</td... |
4b29edb33a357f23d0d93ec010de2648b2833188582e062e218bad3952eecd2c.png | simple | <table><tr><td>Subjects</td><td>Experimental (non obstructive CAD) group (n)</td><td>Control (obstructive CAD) Group (n)</td><td>P value*</td></tr><tr><td>Females</td><td>143</td><td>141</td><td>0.888</td></tr><tr><td>Males</td><td>99</td><td>101</td><td>0.906</td></tr></table> | <table><tr><td>Subjec</td><td>Experimental (non obstructive CAD) group (n)</td><td>Control (obstructive C</td><td>P val</td></tr></table> | <table><tr><td>ts</td><td></td><td>AD) Group (n)</td><td>ue*</td></tr><tr><td>Females</td><td>143</td><td>141</td><td>0.888</td></tr><tr><td>Males</td><td>99</td><td>101</td><td>0.906</td></tr></table> |
f8ba4ee68d2bd983e795745eaf6236c7fe32786af6919046c9de32ae9f5b727c.png | simple | <table><tr><td> </td><td>Input level</td><td>Running speech (mean (dB SPL), SE (dB))</td><td>Isolation (mean (dB SPL), SE (dB))</td><td><i>t</i>-statistic, df</td><td><i>P</i> value</td><td>Critical <i>P</i> value</td></tr><tr><td> </td><td>55</td><td>85.66, 2.28</td><td>83.66, 2.51</td><td>4.437, 9</td><td>0.002*</td>... | <table><tr><td></td><td>Input level</td><td>Running speech (mean (dB SPL), SE (dB))</td><td>Isolation (mean (dB SPL), SE (dB))</td></tr><tr><td></td><td>55</td><td>85.66, 2.28</td><td>83.66, 2.51</td></tr><tr><td>Overall level</td><td>65</td><td>94.61, 2.38</td><td>92.72, 2.55</td></tr><tr><td></td><td>75</td><td>101.9... | <table><tr><td>t-statistic, df</td><td>P value</td><td>Critical P value</td></tr><tr><td>4.437, 9</td><td>0.002*</td><td>0.017</td></tr><tr><td>3.803, 9</td><td>0.004*</td><td>0.033</td></tr><tr><td>1.173, 9</td><td>0.121</td><td>0.050</td></tr><tr><td>4.234, 9</td><td>0.002*</td><td>0.017</td></tr><tr><td>2.739, 9</td... |
057478878be258be0adba4350f350c613e4c34774b3c4f0ff8dca2eae63b44d1.png | complex | <table><tr><td> Methods </td><td> FLAT </td><td> HTD </td><td> HTD-CS </td><td> HB </td><td> HB-CS </td><td> TPR </td><td> TPR-W</td></tr><tr><td colspan="8">Single-source </td></tr><tr><td>BIOGRID</td><td>0.2643</td><td>0.3759</td><td>0.4160</td><td>0.3385</td><td>0.4183</td><td>0.3902</td><td>0.4367</td></tr><tr><td>... | <table><tr><td>Methods</td></tr><tr><td>Single-source</td></tr><tr><td>BIOGRID</td></tr><tr><td>String</td></tr><tr><td>PFAM BINARY</td></tr><tr><td>PFAM LOGE</td></tr><tr><td>Expr.</td></tr><tr><td>Seq. sim.</td></tr><tr><td>Multisource (data fusion)</td></tr><tr><td>Kernel fusion</td></tr></table> | <table><tr><td>FLAT</td><td>HTD</td><td>HTD-CS</td><td>HB</td><td>HB-CS</td><td>TPR</td><td>TPR-W</td></tr><tr><td colspan="7">Single-source</td></tr><tr><td>0.2643</td><td>0.3759</td><td>0.4160</td><td>0.3385</td><td>0.4183</td><td>0.3902</td><td>0.4367</td></tr><tr><td>0.2203</td><td>0.2677</td><td>0.3135</td><td>0.2... |
adfdc518efb80cf97de932cbaddef35efe769a99aed0f24ff5d7bad2c48cf9ff.png | simple | <table><tr><td></td><td>Odds Ratio</td><td>[95% Confidence Interval]</td><td>p-value</td></tr><tr><td>Age group</td><td>1.08</td><td>1.02 - 1.51</td><td>0.02</td></tr><tr><td>Family history of renal disease</td><td>1.12</td><td>0.76 - 1.45</td><td>0.05</td></tr><tr><td>School education</td><td>0.99</td><td>0.76 - 2.54<... | <table><tr><td></td><td>Odds Ratio</td><td>[95% Confidence Interval]</td><td>p-value</td></tr><tr><td>Age group</td><td>1.08</td><td>1.02 - 1.51</td><td>0.02</td></tr><tr><td>Family history of renal disease</td><td>1.12</td><td>0.76 - 1.45</td><td>0.05</td></tr><tr><td>School education</td><td>0.99</td><td>0.76 - 2.54<... | <table><tr><td></td><td>Odds Ratio</td><td>[95% Confidence Interval]</td><td>p-value</td></tr><tr><td>Obesity</td><td>1.33</td><td>1.05 - 1.98</td><td>0.04</td></tr></table> |
05e530e6395d9281c68e01520e3d44fe4848c19d4bace49e3dd093e32c2c8744.png | complex | <table><tr><td>Source of variation</td><td>df</td><td>SSD</td><td>VC</td><td>% total</td><td><i>P</i></td></tr><tr><td colspan="6">1. Regions divided by rivers</td></tr><tr><td> Among regions</td><td>4</td><td>168.349</td><td>0.507</td><td>23.87</td><td><0.001</td></tr><tr><td> Among populations within regions</td><... | <table><tr><td>Source of variation</td><td>df</td><td>SSD</td><td>VC</td><td>% total</td><td>P</td></tr><tr><td colspan="6">1. Regions divided by rivers</td></tr><tr><td>Among regions</td><td>4</td><td>168.349</td><td>0.507</td><td>23.87</td><td><0.001</td></tr></table> | <table><tr><td>Among populations within regions</td><td>44</td><td>356.604</td><td>1.075</td><td>50.60</td><td><0.001</td></tr><tr><td>Within populations</td><td>297</td><td>161.099</td><td>0.542</td><td>25.53</td><td><0.001</td></tr><tr><td>Total</td><td>345</td><td>686.052</td><td>2.125</td><td></td><td></td></tr><tr... |
41fabb6c046a8eec5e57a1bdc44c7f4c7520305a599bfb00e650429801925cc8.png | simple | <table><tr><td>Amplified Region</td><td>Forward</td><td>Reverse</td></tr><tr><td><i>c-KIT </i>exon 8</td><td>5'-CAGCAGTCTGACCTATGGC -3'</td><td>5'-GCTCAGCTCCTGGACAGAAA-3'</td></tr><tr><td><i>c-KIT </i>exon 9</td><td>5'-GATTGATTGATTGATTTTCCTAG-3'</td><td>5'-GCAGGCAGAGCCTAAACATC-3'</td></tr><tr><td><i>c-KIT </i>exon 11</... | <table><tr><td>Amplified Region</td><td>Forward</td><td>Reverse</td></tr><tr><td>c-KIT exon 8</td><td>5'-CAGCAGTCTGACCTATGGC -3'</td><td>5'-GCTCAGCTCCTGGACAGAAA-3'</td></tr><tr><td>c-KIT exon 9</td><td>5'-GATTGATTGATTGATTTTCCTAG-3'</td><td>5'-GCAGGCAGAGCCTAAACATC-3'</td></tr></table> | <table><tr><td>c-KIT exon 11</td><td>5'-CATTTGTTCTCTACCCTAAGTGCT-3'</td><td>5'-GTTCCCTAAAGTCATTGTTACACG-3'</td></tr><tr><td>c-KIT exon 13</td><td>5'-CTGATTAAGTCGGATGCGGC-3'</td><td>5'-CAAGCACTGTCGCAATGG-3'</td></tr><tr><td>c-KIT exon 17</td><td>5'-ATAGCAGCATTCTCGTGTTG-3'</td><td>5'-AACTAAAATCCTTCACTGGACTG-3'</td></tr><... |
52ef4c941df4e854e5cf74e0e427b0b19ec6672c82336e3976c9abb9decd7601.png | complex | <table><tr><td>Year range</td><td>No. records</td><td>Mortality (%)</td><td>Countries</td></tr><tr><td colspan="4"><i>An. arabiensis</i></td></tr><tr><td rowspan="3">Up to 2000 (first year = 1996)</td><td rowspan="3">3</td><td>Min 100</td><td rowspan="3">South Africa</td></tr><tr><td>Max 100</td></tr><tr><td><i>Mean 10... | <table><tr><td>Year range</td><td>No. records</td><td>Mortality (%)</td><td>Countries</td></tr><tr><td colspan="4">An. arabiensis</td></tr><tr><td rowspan="3">Up to 2000 (first year = 1996)</td><td rowspan="3">3</td><td>Min 100</td><td rowspan="3">South Africa</td></tr><tr><td>Max 100</td></tr><tr><td>Mean 100</td></tr... | <table><tr><td rowspan="3">2011–2015</td><td rowspan="3">44</td><td>Min 1</td><td rowspan="3">Benin, Burkina Faso, Cameroon, Côte d’Ivoire, Mali, Mozambique, Liberia</td></tr><tr><td>Max 100</td></tr><tr><td>Mean 60.6</td></tr><tr><td colspan="4">An. gambiae</td></tr><tr><td rowspan="3">Up to 2000 (first year = 1999)<... |
b06f5ae136f87bc075411a0dd941199edb2e5e91bb029e39de9ef6b4207f9285.png | complex | <table><tr><td></td><td colspan="3">Ukraine</td><td colspan="3">Kazakhstan</td><td colspan="3">Azerbaijan</td></tr><tr><td></td><td colspan="2">Respondents<sup>a</sup></td><td></td><td colspan="2">Respondents<sup>a</sup></td><td></td><td colspan="2">Respondents<sup>a</sup></td><td></td></tr><tr><td></td><td>without BA<... | <table><tr><td></td><td colspan="3">Ukraine</td><td colspan="3">Kazakhstan</td><td colspan="3">Azerbaijan</td></tr><tr><td></td><td colspan="2">Respondentsa</td><td></td><td colspan="2">Respondentsa</td><td></td><td colspan="2">Respondentsa</td><td></td></tr><tr><td></td><td>without BA</td><td>with BA</td><td>p-value</... | <table><tr><td>Hypertension, %</td><td>13.1</td><td>37.1</td><td>< 0.001</td><td>21.6</td><td>40.1</td><td>< 0.001</td><td>16.2</td><td>27.0</td><td>0.006</td></tr><tr><td>Diabetes, %</td><td>3.2</td><td>5.7</td><td>0.291</td><td>3.5</td><td>4.2</td><td>0.689</td><td>4.8</td><td>9.6</td><td>0.044</td></tr><tr><td>Cardi... |
7d86d11100ebee3351cb48225c55062310d6ed00eeabeb31db1bab12bb8eef82.png | complex | <table><tr><td></td><td colspan="3">Australia</td><td colspan="3">Spain</td><td colspan="3">UK</td><td></td><td>Total</td></tr><tr><td>Predictor</td><td>No./total cases<sup>1</sup></td><td>%</td><td>OR<sup>2</sup> (95% CI)</td><td>No./total cases</td><td>%</td><td>OR (95% CI)</td><td>No./total cases</td><td>%</td><td>O... | <table><tr><td></td><td colspan="3">Australia</td><td colspan="3">Spain</td><td colspan="3">UK</td><td></td><td>Total</td></tr><tr><td>Predictor</td><td>No./total cases1</td><td>%</td><td>OR2 (95% CI)</td><td>No./total cases</td><td>%</td><td>OR (95% CI)</td><td>No./total cases</td><td>%</td><td>OR (95% CI)</td><td>%</... | <table><tr><td></td><td colspan="2">Australia</td><td colspan="3">Spain</td><td colspan="3">UK</td><td></td><td>Total</td></tr><tr><td>Predictor</td><td>No./total cases1</td><td>%</td><td>No./total cases</td><td>%</td><td>OR (95% CI)</td><td>No./total cases</td><td>%</td><td>OR (95% CI)</td><td>%</td><td>Multivariate O... |
10246ad35deff509f26a006d4a4e03e7d1a999ee9659fcd93b2419e14b13f6c7.png | complex | <table><tr><td></td><td colspan="2">Untreated n. 77</td><td colspan="2">IFN-β treated n.41</td><td colspan="2">p-value*</td></tr><tr><td><i>Time-varying covariates</i></td><td><i>Baseline</i></td><td><i>Change</i></td><td><i>Baseline</i></td><td><i>Change</i></td><td><i>Baseline</i></td><td><i>Change</i></td></tr>... | <table><tr><td></td><td colspan="2">Untreated n. 77</td><td colspan="2">IFN-β treated n.41</td><td colspan="2">p-value*</td></tr><tr><td>Time-varying covariates</td><td>Baseline</td><td>Change</td><td>Baseline</td><td>Change</td><td>Baseline</td><td>Change</td></tr><tr><td>Relapse rate**</td><td>0.2 ± 0.3</td><td>0.0 ±... | <table><tr><td>Sexual function</td><td>83.1 ± 26.6</td><td>-6.0 ± 35.6</td><td>81.5 ± 27.0</td><td>-12.0 ± 36.5</td><td>0.67</td><td>0.62</td></tr><tr><td>Social function</td><td>74.2 ± 23.3</td><td>-5.8 ± 23.4</td><td>74.4 ± 21.3</td><td>-10.0 ± 21.5</td><td>0.87</td><td>0.49</td></tr><tr><td>Health distress</td><td>7... |
726dfd87827af4e74c73a4a4dea3fbbbc750bee2045f3866936958bf5dbe3c4b.png | complex | <table><tr><td colspan="4">Primary antibodies</td><td colspan="4">Secondary antibodies</td></tr><tr><td>Antibody</td><td>Company</td><td>Tissue</td><td>Dilution</td><td>Antibody</td><td>Company</td><td>Tissue</td><td>Dilution</td></tr><tr><td>Brn-3a</td><td>Santa Cruz</td><td>Retina</td><td>1:100</td><td>Donkey anti-go... | <table><tr><td colspan="4">Primary antibodies</td><td colspan="4">Secondary antibodies</td></tr><tr><td>Antibody</td><td>Company</td><td>Tissue</td><td>Dilution</td><td>Antibody</td><td>Company</td><td>Tissue</td><td>Dilution</td></tr><tr><td>Brn-3a</td><td>Santa Cruz</td><td>Retina</td><td>1:100</td><td>Donkey anti-go... | <table><tr><td></td><td></td><td>Optic nerve</td><td>1:500</td><td></td><td></td><td>Optic nerve</td><td>1:500</td></tr><tr><td>C5b-9 (MAC)</td><td>Biozol</td><td>Retina</td><td>1:100</td><td>Donkey anti-mouse Dy Light 488</td><td>Dianova</td><td>Retina</td><td>1:250</td></tr><tr><td></td><td></td><td>Optic nerve</td><... |
e2f53f9adf3fbd9ea1a7e041ecd0be70cf539741ed67836646a0b73c5c5adbec.png | complex | <table><tr><td></td><td colspan="2">Control</td><td colspan="2">Minority frame</td><td colspan="2">Majority frame</td></tr><tr><td>Cookie acceptance</td><td>No</td><td>Yes</td><td>No</td><td>Yes</td><td>No</td><td>Yes</td></tr><tr><td>Low impulsivity</td><td>31% (14)</td><td>69% (31)</td><td>54% (37)</td><td>46% (32)</... | <table><tr><td></td></tr><tr><td>Cookie acceptance</td></tr><tr><td>Low impulsivity</td></tr><tr><td>N</td></tr><tr><td>High impulsivity</td></tr><tr><td>N</td></tr><tr><td>Low risk</td></tr><tr><td>n</td></tr><tr><td>High risk</td></tr><tr><td>n</td></tr></table> | <table><tr><td colspan="2">Control</td><td colspan="2">Minority frame</td><td colspan="2">Majority frame</td></tr><tr><td>No</td><td>Yes</td><td>No</td><td>Yes</td><td>No</td><td>Yes</td></tr><tr><td>31% (14)</td><td>69% (31)</td><td>54% (37)</td><td>46% (32)</td><td>23% (13)</td><td>77% (43)</td></tr><tr><td colspan="... |
b5b72b492d701c48e4cf3a7da2bd339b7d4930a27f7ec6787b67d0074b543899.png | simple | <table><tr><td>BaP</td><td></td><td>XPA</td><td>XPC</td><td>ERCC4</td><td>ERCC5</td><td>ERCC1</td></tr><tr><td>0 μM</td><td>RCC4-<i>VHL</i></td><td>1.00 ± 0.02</td><td>1.00 ± 0.14</td><td>1.00 ± 0.08</td><td>1.00 ± 0.10</td><td>1.00 ± 0.09</td></tr><tr><td></td><td>RCC4</td><td>0.94 ±... | <table><tr><td>BaP</td><td></td><td>XPA</td><td>XPC</td><td>ERCC4</td><td>ERCC5</td><td>ERCC1</td></tr><tr><td></td><td>RCC4</td><td>1.00</td><td>1.</td><td>1.00 ± </td><td>1.</td><td>1.</td></tr></table> | <table><tr><td>BaP</td><td></td><td>XPA</td><td>XPC</td><td>ERCC4</td><td>ERCC5</td><td>ERCC1</td></tr><tr><td>0 μM</td><td>-VHL</td><td> ± 0.02</td><td>00 ± 0.14</td><td>0.08</td><td>00 ± 0.10</td><td>00 ± 0.09</td></tr><tr><td></td><td>RCC4</td><td>0.94 ± 0.05</td><td>0.98 ± 0.12</td><td>0.98 ± 0.03</td><td>1.16 ± 0.... |
ba8c228812b528a7ae0d75fc6786b2f87b48168dabef6f16943b04b2b640f082.png | simple | <table><tr><td>Federal state</td><td>Percentage Av positive in total (x/y) [95% CI]</td><td>Percentage Cv positive in total (x/y) [95% CI]</td><td>Percentage Ea positive in total (x/y) [95% CI]</td><td>Percentage Av + Cv positive (x/y) [95% CI]</td><td>Percentage Av + Ea positive (x/y) [95% CI]</td><td>Percentage Cv + ... | <table><tr><td>Federal state</td><td>Percentage Av positive in total (x/y) [95% CI]</td><td>Percentage Cv positive in total (x/y) [95% CI]</td><td>Percentage Ea positive in total (x/y) [95% CI]</td><td>Percentage Av + Cv positive (x/y) [95% CI]</td><td>Percentage Av + Ea positive (x/y) [95% CI]</td><td>Percentage Cv + ... | <table><tr><td>Hesse</td><td>19.1 (17/89)[11.5–28.8]</td><td>30.3 (27/89)[21.0–41.0]</td><td>71.9 (64/89)[61.4–80.9]</td><td>1.1 (1/89)[0.0–6.1]</td><td>11.2 (10/89)[5.5–19.7]</td><td>23.6 (21/89)[15.2–33.8]</td><td>4.5 (4/89)[1.2–11.1]</td></tr><tr><td>Rhineland-Palatinate</td><td>27.3 (33/121)[19.6–36.1]</td><td>25.6... |
36670078cc13d905b24dc209d9a21e9859d2c46c28f90192554f70d9feca02f7.png | complex | <table><tr><td> </td><td> </td><td>Baseline</td><td>Two sessions</td><td>After pre-treatment</td><td>Start pain rehab treatment</td><td>Finish pain rehab treatment</td><td>6 months after T3</td></tr><tr><td> </td><td>Abbr.</td><td>T0<sup>a</sup></td><td> </td><td>T1</td><td>T2<sup>a</sup></td><td>T3<sup>a</sup></td><td... | <table><tr><td></td><td></td><td>Baseline</td><td>Two sessions</td></tr><tr><td></td><td>Abbr.</td><td>T0a</td><td></td></tr><tr><td colspan="4">Covariates</td></tr><tr><td>Demographics patient</td><td></td><td>x</td><td></td></tr><tr><td colspan="4">Primary outcome effect evaluation</td></tr><tr><td>Participation</td>... | <table><tr><td>After pre-treatment</td><td>Start pain rehab treatment</td><td>Finish pain rehab treatment</td><td>6 months after T3</td></tr><tr><td>T1</td><td>T2a</td><td>T3a</td><td>T4</td></tr><tr><td colspan="4">Covariates</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td colspan="4">Primary outcome eff... |
23a4c9b133d9651c69d3a425a8ae5c9f1eb4250fc16c6e6ea756acad88994c66.png | complex | <table><tr><td rowspan="2">Activity limitation</td><td colspan="2">No</td><td colspan="2">Some</td><td colspan="2">Profound</td></tr><tr><td>Percentage with health indicator<sup>a</sup></td><td>RR (95% CI)<sup>b</sup></td><td>Percentage with health indicator<sup>a</sup></td><td>RR (95% CI)<sup>b</sup></td><td>Percentag... | <table><tr><td rowspan="2">Activity limitation</td><td colspan="2">No</td></tr><tr><td>Percentage with health indicatora</td><td>RR (95% CI)b</td></tr><tr><td colspan="3">Health and well-being</td></tr><tr><td>Poor self-perceived health</td><td>2.2</td><td>1</td></tr><tr><td>Poor dental status</td><td>9.5</td><td>1</td... | <table><tr><td colspan="2">Some</td><td colspan="2">Profound</td></tr><tr><td>Percentage with health indicatora</td><td>RR (95% CI)b</td><td>Percentage with health indicatora</td><td>RR (95% CI)b</td></tr><tr><td colspan="4">Health and well-being</td></tr><tr><td>27.4</td><td>1.33 (1.32–1.37)</td><td>64.8</td><td>2.78 ... |
5893f666fdf2da87a8ac416ccf57340962b1e070e1c05ec1529689aeff9c4b71.png | simple | <table><tr><td></td><td>Mean growth rate (SD) non-manual social class</td><td>Mean difference (95% CI) manual vs. non-manual social class</td></tr><tr><td>Birth length, cm Growth rate, cm/month</td><td>50.173 (1.642)</td><td>−0.439 (−0.599 to −0.279)</td></tr><tr><td> 0–3 months</td><td>3.553 (0... | <table><tr><td></td><td>Mean growth rate (SD) non-manual social class</td><td>Mean difference (95% CI) manual vs. non-manual social class</td></tr><tr><td>Birth length, cm Growth rate, cm/month</td><td>50.173 (1.642)</td><td>−0.439 (−0.599 to −0.279)</td></tr><tr><td>0–3 months</td><td>3.553 (0.241)</td><td>0.087 (0.01... | <table><tr><td></td><td>Mean growth rate (SD) non-manual social class</td><td>Mean difference (95% CI) manual vs. non-manual social class</td></tr><tr><td></td><td></td><td></td></tr><tr><td>1–3 years</td><td>0.836 (0.071)</td><td>−0.015 (−0.026 to −0.005)</td></tr><tr><td>3–10 years</td><td>0.531 (0.035)</td><td>−0.00... |
4d58ad5975b1b9f847ae98a4409596bd1183c415e105939d3c862ea5eed1ebf1.png | simple | <table><tr><td>Method</td><td>Total number</td><td>Disorder number</td><td>Success rate</td></tr><tr><td>Subcutaneous injection of sesame oil</td><td>10</td><td>0</td><td>0.00%</td></tr><tr><td>Subcutaneous injection of DHEA</td><td>40</td><td>25</td><td>62.50%</td></tr></table> | <table><tr><td>Method</td><td>Total number</td><td>Disorder number</td><td>Success rate</td></tr></table> | <table><tr><td>Subcutaneous injection of sesame oil</td><td>10</td><td>0</td><td>0.00%</td></tr><tr><td>Subcutaneous injection of DHEA</td><td>40</td><td>25</td><td>62.50%</td></tr></table> |
98a917c013cbf2f40d7a1fca1991829d2947bf00f81fd3c735b6df089c1f0b1e.png | complex | <table><tr><td colspan="2">PBMS</td><td colspan="4">Comparison of PBMS parameters between study groups</td></tr><tr><td colspan="2">Domains</td><td>control</td><td>intervention</td><td>range</td><td>p</td></tr><tr><td> </td><td>Sub-domains</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td colspan="2">1 Attitude<... | <table><tr><td colspan="2">PBMS</td><td colspan="4">Comparison of PBMS parameters between study groups</td></tr><tr><td colspan="2">Domains</td><td>control</td><td>intervention</td><td>range</td><td>p</td></tr><tr><td></td><td>Sub-domains</td><td></td><td></td><td></td><td></td></tr><tr><td colspan="2">1 Attitude</td><... | <table><tr><td colspan="2">PBMS</td><td colspan="4">Comparison of PBMS parameters between study groups</td></tr><tr><td colspan="2">Domains</td><td>control</td><td>intervention</td><td>range</td><td>p</td></tr><tr><td></td><td>Sub-domains</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>a: assumed attitude... |
8dae2664a4552b96ed75e889ec3b6cde0886afaf75768e215dc5dc95a6c3b1d1.png | simple | <table><tr><td>Objective</td><td>Control Group</td><td>Coadministration Group</td><td>Noninferiority Analysis</td></tr><tr><td>Primary objectives</td><td></td><td></td><td></td></tr><tr><td> HZ/su VRR (95% CI), %<sup>b</sup></td><td>n = 388</td><td>n = 382</td><td>...</td></tr><tr><td></td><td>97.9 (96.0–99.1)</t... | <table><tr><td>Objective</td><td>Control Group</td><td>Coadministration Group</td><td>Noninferiority Analysis</td></tr><tr><td>Primary objectives</td><td></td><td></td><td></td></tr><tr><td>HZ/su VRR (95% CI), %b</td><td>n = 388</td><td>n = 382</td><td>...</td></tr><tr><td></td><td>97.9 (96.0–99.1)</td><td>95.8 (93.3–9... | <table><tr><td>B/Yamagata</td><td>37.6 (32.8–42.6)</td><td>40.1 (35.2–45.2)</td><td>−2.54 (−9.37 to 4.31)d</td></tr></table> |
b9a89a98610e3fd00f15f080823510bf627984236665c1a8a5a10cca9dbceb5a.png | complex | <table><tr><td></td><td colspan="4">Estimates</td><td colspan="6">Local adaptation contrasts</td></tr><tr><td>Measure (n)</td><td>Local scale (1)</td><td>Small scale (2)</td><td>Intermediate scale (3)</td><td>Large-scale (4)</td><td>1 vs. 2</td><td>1 vs. 3</td><td>1 vs. 4</td><td>1 + 2 vs. 3</td><td>1 + 2 vs. 4</td><td... | <table><tr><td></td><td colspan="4">Estimates</td><td colspan="6">Local adaptation contrasts</td></tr><tr><td>Measure (n)</td><td>Local scale (1)</td><td>Small scale (2)</td><td>Intermediate scale (3)</td><td>Large-scale (4)</td><td>1 vs. 2</td><td>1 vs. 3</td><td>1 vs. 4</td><td>1 + 2 vs. 3</td><td>1 + 2 vs. 4</td><td... | <table><tr><td>Time to sporulation (n > 667)</td><td>8.275</td><td>8.437</td><td>8.261</td><td>8.174</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>0.08</td><td>0.10</td></tr><tr><td>Aggressiveness (n > 660)</td><td>3.156</td><td>3.092</td><td>3.196</td><td>3.238</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td... |
f7eaca424474eb4512baa954e6dc2284b58d74719b63da488112315f0fdeaf21.png | complex | <table><tr><td>Groups</td><td>UACR (mg/g)</td><td>Total</td></tr><tr><td>Normal albuminuria (NA) (<i>n</i> = 35)</td><td>UACR < 30</td><td rowspan="3"><i>n</i> = 80</td></tr><tr><td>Microalbuminuria (MA) (<i>n</i> = 30)</td><td>30 ≤ UACR < 300</td></tr><tr><td>Clinical albuminuria (CA) (<i>n</i> = 15)</td><... | <table><tr><td>Groups</td><td>UACR (mg/g)</td><td>Total</td></tr><tr><td>Normal albuminuria (NA) (n = 35)</td><td>UACR < 30</td><td>n = 80</td></tr></table> | <table><tr><td>Groups</td><td>UACR (mg/g)</td><td>Total</td></tr><tr><td>Microalbuminuria (MA) (n = 30)</td><td>30 ≤ UACR < 300</td><td rowspan="2">n = 80</td></tr><tr><td>Clinical albuminuria (CA) (n = 15)</td><td>UACR ≥ 300</td></tr><tr><td>Normal group (NC) (n = 80)</td><td>Non-diabetic subjects</td><td>n = 80</td><... |
3e76bcf11062f7b70828881372569e1d52f159fb1b202a18cb9315aa31cf8b8c.png | complex | <table><tr><td>Factors related to attitude</td><td>Number</td><td>Mean score</td><td>SD</td><td><i>P</i> – Value</td></tr><tr><td>Location</td><td>396</td><td>78.52</td><td>14.97</td><td></td></tr><tr><td>Rural</td><td>306</td><td>77.78</td><td>14.97</td><td rowspan="2"><i>P =</i> 0.066</td></tr><tr><td>Urban</td... | <table><tr><td>Factors related to attitude</td><td>Number</td></tr><tr><td>Location</td><td>396</td></tr><tr><td>Rural</td><td>306</td></tr><tr><td>Urban</td><td>90</td></tr><tr><td>Age</td><td>396</td></tr><tr><td>18–24 Years</td><td>24</td></tr><tr><td>25–34 Years</td><td>89</td></tr><tr><td>35–44 Years</td><td>135</... | <table><tr><td>Mean score</td><td>SD</td><td>P – Value</td></tr><tr><td>78.52</td><td>14.97</td><td></td></tr><tr><td>77.78</td><td>14.97</td><td rowspan="2">P = 0.066</td></tr><tr><td>81.02</td><td>13.74</td></tr><tr><td>78.52</td><td>14.75</td><td></td></tr><tr><td>82.96</td><td>13.28</td><td rowspan="5">P = 0.000</t... |
472eea06e69a0a725aedc2ea8e070ac308a730e0277e21d5f43447de860f94ca.png | complex | <table><tr><td></td><td colspan="3">All patients</td><td colspan="3">CN-AML patients</td></tr><tr><td>Final model</td><td>HR</td><td>95% CI</td><td>P-value</td><td>HR</td><td>95% CI</td><td>P-value</td></tr><tr><td>Presence of unfavorable karyotype</td><td>2.54</td><td>1.56–4.12</td><td><0.001</td><td>NA</td><... | <table><tr><td></td><td>All patients</td></tr><tr><td>Final model</td><td>HR</td></tr><tr><td>Presence of unfavorable karyotype</td><td>2.54</td></tr><tr><td>Presence of SNP-A lesion(s)</td><td>2.25</td></tr><tr><td>Presence of NPM1 mutation</td><td>1.12</td></tr><tr><td>Presence of EVI1 overexpression</td><td>1.63</td... | <table><tr><td colspan="2">All patients</td><td colspan="3">CN-AML patients</td></tr><tr><td>95% CI</td><td>P-value</td><td>HR</td><td>95% CI</td><td>P-value</td></tr><tr><td>1.56–4.12</td><td><0.001</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>1.39–3.65</td><td>0.001</td><td>2.38</td><td>1.28–4.43</td><td>0.006</... |
0ab9ab9d8282f0117ae313059acf566de7858effe943bf0f9c053f36bcdf572c.png | complex | <table><tr><td rowspan="2">Closest taxon </td><td rowspan="2">Log inactivation</td><td colspan="4">Resistance (log<sub>10</sub>(CFU·100 mL<sup>−</sup><sup>1</sup>))</td></tr><tr><td>Maximum</td><td>Treatment</td><td>Minimum </td><td>Treatment </td></tr><tr><td><i>A. hydrophila</i></td><td>0.84</td><td>10.43<... | <table><tr><td rowspan="2">Closest taxon</td><td rowspan="2">Log inactivation</td><td colspan="4">Resistance (log10(CFU·100 mL−1))</td></tr><tr><td>Maximum</td><td>Treatment</td><td>Minimum</td><td>Treatment</td></tr><tr><td>A. hydrophila</td><td>0.84</td><td>10.43</td><td>TI 30 mg·L−g/15 min</td><td>11.27</td><td>TII ... | <table><tr><td>E. coli BL21</td><td>0.80</td><td>10.37</td><td>TI 8 mg·L−g/0 min</td><td>11.18</td><td>TII 20 mg·L−g/0 min</td></tr><tr><td>E. cloacae</td><td>0.81</td><td>10.38</td><td>TIII 30 mg·L−g/30 min</td><td>11.19</td><td>TIII 8 mg·L−g/0 min</td></tr></table> |
47627a4e95a2baf011823c702c1f6673b6d4b3f064fe363e0a8b4d848e10cc94.png | simple | <table><tr><td>Characteristic</td><td>EBT (<i>n</i> = 7)</td><td>3DRT (<i>n</i> = 14)</td><td>IMRT (<i>n</i> = 11)</td><td><i>P</i></td></tr><tr><td>Age (mean ± SD)</td><td>60.4 ± 17.4</td><td>58.2 ± 12.0</td><td>52.3 ± 7.6</td><td>0.32</td></tr><tr><td>Sex (female%)</td><td>100</td><td>29</td><td>6... | <table><tr><td>Characteristic</td><td>EBT (n = 7)</td><td>3DRT (n = 14)</td><td>IMRT (n = 11)</td><td>P</td></tr><tr><td>Age (mean ± SD)</td><td>60.4 ± 17.4</td><td>58.2 ± 12.0</td><td>52.3 ± 7.6</td><td>0.32</td></tr><tr><td>Sex (female%)</td><td>100</td><td>29</td><td>64</td><td>0.007</td></tr><tr><td>Race (Caucasian... | <table><tr><td>Characteristic</td><td>EBT (n = 7)</td><td>3DRT (n = 14)</td><td>IMRT (n = 11)</td><td>P</td></tr><tr><td>Number N0 (%)</td><td>4 (57)</td><td>4 (29)</td><td>3 (27)</td><td>0.36</td></tr><tr><td>Number N1 (%)</td><td>3 (43)</td><td>8 (57)</td><td>6 (55)</td><td>0.82</td></tr><tr><td>Number N2 (%)</td><td... |
2153ceb42b9bdde752a5de70835760f5c6d7e7ef61b7b34530a23e2830e936a4.png | simple | <table><tr><td>Characteristics</td><td>Fresh frozen tissue (%)</td><td>Paraffin-embedded tissue (%)</td></tr><tr><td>Gender</td><td> </td><td> </td></tr><tr><td>Male</td><td>103 (66)</td><td>88 (56)</td></tr><tr><td>Female</td><td>53 (34)</td><td>70 (44)</td></tr><tr><td>Age (years)</td><td> </td><td> </td></tr><tr><td... | <table><tr><td>Characteristics</td></tr><tr><td>Gender</td></tr><tr><td>Male</td></tr><tr><td>Female</td></tr><tr><td>Age (years)</td></tr><tr><td><70</td></tr><tr><td>≥70</td></tr><tr><td>Location</td></tr><tr><td>Colon</td></tr><tr><td>Rectum</td></tr><tr><td>Stage</td></tr><tr><td>I</td></tr><tr><td>II</td></tr><tr>... | <table><tr><td>Fresh frozen tissue (%)</td><td>Paraffin-embedded tissue (%)</td></tr><tr><td></td><td></td></tr><tr><td>103 (66)</td><td>88 (56)</td></tr><tr><td>53 (34)</td><td>70 (44)</td></tr><tr><td></td><td></td></tr><tr><td>48 (32)</td><td>59 (37)</td></tr><tr><td>104 (68)</td><td>99 (63)</td></tr><tr><td></td><t... |
89c67e5d4a4b184127b31a62218c0bc755ab784115457e4ca6cb1b78974ce97b.png | complex | <table><tr><td></td><td></td><td>All patients</td><td colspan="2">Anti-CCP</td><td><i>P </i>value</td></tr><tr><td></td><td></td><td></td><td>Negative</td><td>Positive</td><td></td></tr><tr><td>Age</td><td><50*</td><td>45 (75%)</td><td>8 (17.8%)</td><td>37 (82.2%)</td><td>NS</td></tr><tr><td></td><td>≥50</td><... | <table><tr><td></td><td></td><td>All patients</td><td colspan="2">Anti-CCP</td><td>P value</td></tr><tr><td></td><td></td><td></td><td>Negative</td><td>Positive</td><td></td></tr><tr><td>Age</td><td><50*</td><td>45 (75%)</td><td>8 (17.8%)</td><td>37 (82.2%)</td><td>NS</td></tr><tr><td></td><td>≥50</td><td>15 (25%)</td>... | <table><tr><td></td><td></td><td>All patients</td><td colspan="2">Anti-CCP</td><td>P value</td></tr><tr><td></td><td></td><td></td><td>Negative</td><td>Positive</td><td></td></tr><tr><td>R-1</td><td> *</td><td>%)</td><td>35.7%)</td><td>3%)</td><td>04</td></tr><tr><td></td><td>≥32</td><td>46 (76.7%)</td><td>5 (10.9%)</t... |
2bba4c29f3f6c1670fcee3b6c1659da8dab28034e4fc4c9eb2ab3dc832caa2dc.png | simple | <table><tr><td>Characteristics</td><td>Synbiotics (<i>n</i> = 43)</td><td>Placebo (<i>n</i> = 42)</td><td><i>p</i>-Value</td></tr><tr><td>Sex *</td><td></td><td></td><td></td></tr><tr><td> Male</td><td>7 (16.3)</td><td>5 (11.9)</td><td>0.533</td></tr><tr><td> Female</td><td>36 (83.7)</td><td>37 (88.1)</td><td></td></tr... | <table><tr><td>Characteristics</td><td>Synbiotics (n = 43)</td><td>Placebo (n = 42)</td><td>p-Value</td></tr><tr><td>Sex *</td><td></td><td></td><td></td></tr><tr><td>Ma</td><td>7 (16</td><td>5 (11.9</td><td>0.5</td></tr></table> | <table><tr><td>Characteristics</td><td>Synbiotics (n = 43)</td><td>Placebo (n = 42)</td><td>p-Value</td></tr><tr><td>le</td><td>.3)</td><td>)</td><td>33</td></tr><tr><td>Female</td><td>36 (83.7)</td><td>37 (88.1)</td><td></td></tr><tr><td>Age (years) φ</td><td>29.5 ± 8.34</td><td>27.5 ± 6.5</td><td>0.368</td></tr><tr><... |
89e80e1f26c7ef4f439e47fa9815aed670e0815e1db00a5d444d5b20d371f15b.png | simple | <table><tr><td></td><td></td><td>Germany</td><td>Greece</td><td>Norway</td><td>Spain</td><td>Sweden</td><td>UK</td></tr><tr><td>Absenteeism, hours/week</td><td>n</td><td>187</td><td>249</td><td>233</td><td>131</td><td>196</td><td>132</td></tr><tr><td></td><td></td><td>3.2 (8.8)</td><td>1.5 (5.1)</td><td>0.9 (4.7)</td><... | <table><tr><td></td><td></td><td>Germany</td><td>Greece</td><td>Norway</td><td>Spain</td><td>Sweden</td><td>UK</td></tr></table> | <table><tr><td>Absenteeism, hours/week</td><td>n</td><td>187</td><td>249</td><td>233</td><td>131</td><td>196</td><td>132</td></tr><tr><td></td><td></td><td>3.2 (8.8)</td><td>1.5 (5.1)</td><td>0.9 (4.7)</td><td>2.1 (7.1)</td><td>0.7 (3.4)</td><td>0.4 (2.7)</td></tr><tr><td>Presenteeism (work hours lost/week due to reduc... |
8f8e6e01a3582ae7b0a0c882525d582133f939fddc569fdfdb03bfb956636926.png | complex | <table><tr><td rowspan="2">Phylogenetic Group</td><td colspan="10">A</td><td rowspan="2" colspan="3">B</td></tr><tr><td colspan="5">A1</td><td colspan="4">A2</td><td>A3</td></tr><tr><td>Predicted CDS</td><td>EhV-84</td><td>EhV-86</td><td>EhV-88</td><td>EhV-145</td><td>EhV-164</td><td>EhV-201</td><td>EhV-203</td><td>EhV... | <table><tr><td rowspan="2">Phylogenetic Group</td><td colspan="4">A</td></tr><tr><td colspan="4">A1</td></tr><tr><td>Predicted CDS</td><td>EhV-84</td><td>EhV-86</td><td>EhV-88</td><td>EhV-145</td></tr><tr><td>hypothetical protein</td><td>27</td><td>3</td><td>4</td><td>7</td></tr><tr><td>putative endonuclease</td><td></... | <table><tr><td colspan="6">A</td><td rowspan="2" colspan="3">B</td></tr><tr><td>A1</td><td colspan="4">A2</td><td>A3</td></tr><tr><td>EhV-164</td><td>EhV-201</td><td>EhV-203</td><td>EhV-207</td><td>EhV-208</td><td>EhV-99B1</td><td>EhV-202</td><td>EhV-18</td><td>EhV-156</td></tr><tr><td>8</td><td>4</td><td>4</td><td>9</... |
d9c59573b9ad1fe058339bffef81c349fefcd297cf972544d0f9a22924653e02.png | simple | <table><tr><td>study</td><td><i>y</i><sub><i>i</i>1</sub></td><td><i>y</i><sub><i>i</i>2</sub></td><td><i>n</i><sub><i>i</i>1</sub></td><td><i>n</i><sub><i>i</i>2</sub></td><td><i>p</i><sub><i>i</i>1</sub></td><td><i>p</i><sub><i>i</i>2</sub></td></tr><tr><td>1</td><td>14</td><td>14</td><td>131</td><td>136</td><td>0.10... | <table><tr><td>study</td><td>yi1</td><td>yi2</td><td>ni1</td><td>ni2</td><td>pi1</td><td>pi2</td></tr><tr><td></td><td>1</td><td>1</td><td>1</td><td></td><td></td><td></td></tr></table> | <table><tr><td>1</td><td>4</td><td>4</td><td>31</td><td>136</td><td>0.1068</td><td>0.1029</td></tr><tr><td>2</td><td>21</td><td>17</td><td>385</td><td>134</td><td>0.0545</td><td>0.1268</td></tr><tr><td>3</td><td>14</td><td>24</td><td>57</td><td>48</td><td>0.2456</td><td>0.5000</td></tr><tr><td>4</td><td>6</td><td>18</t... |
3e62911ddaf3a4d3f260b125c47b3a0d98ae59af5b916d5969651bb0ad2da449.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2">Exposure time [min]</td><td colspan="3">HIV-1 titer [TCID<sub>50</sub>/ml] after exposure to uncoated and coated coverslip and after washing with 0.49 ml of PBS</td><td rowspan="2">HIV-1 titer reduction<sup><i>a</i></sup></td><td rowspan="2"><i>p</i>-value<sup><i>b</i></s... | <table><tr><td rowspan="2"></td><td rowspan="2">Exposure time [min]</td><td colspan="3">HIV-1 titer [TCID50/ml] after exposure to uncoated and coated coverslip and after washing with 0.49 ml of PBS</td><td rowspan="2">HIV-1 titer reductiona</td><td rowspan="2">p-valueb</td></tr><tr><td>Coverslip #1</td><td>Coverslip #2... | <table><tr><td rowspan="2"></td><td rowspan="2">Exposure time [min]</td><td colspan="3">HIV-1 titer [TCID50/ml] after exposure to uncoated and coated coverslip and after washing with 0.49 ml of PBS</td><td rowspan="2">HIV-1 titer reductiona</td><td rowspan="2">p-valueb</td></tr><tr><td>Coverslip #1</td><td>Coverslip #2... |
b7b1ea725f95297c323bdba5d2fb5f0852ace7e37eb8d72c7de5fdcb6f1a7c47.png | simple | <table><tr><td>Gender</td><td>Functional dyspepsia</td><td>Organic dyspepsia</td><td>Total</td></tr><tr><td>Male</td><td>72 </td><td>40</td><td>112</td></tr><tr><td>Female</td><td>120</td><td>64</td><td>184</td></tr><tr><td>Total</td><td>192</td><td>104</td><td>296</td></tr></table> | <table><tr><td>Gender</td><td>Functional dyspepsia</td><td>Organic dyspepsia</td><td>Total</td></tr><tr><td>Male</td><td>72</td><td>40</td><td>112</td></tr></table> | <table><tr><td>Gender</td><td>Functional dyspepsia</td><td>Organic dyspepsia</td><td>Total</td></tr><tr><td>Female</td><td>120</td><td>64</td><td>184</td></tr><tr><td>Total</td><td>192</td><td>104</td><td>296</td></tr></table> |
4c1a255b4ee781b18b935ac56c71cf078528f58a30e06c42ddb15ff16473fa20.png | simple | <table><tr><td>Names</td><td>Sequence (5′–3′)</td><td>T<sub>m</sub> (°C)</td><td><i>M</i>w</td></tr><tr><td><i>Osa-miR156</i></td><td>UGA CAG AAG AGA GUG AGC AC</td><td>57.3</td><td>6279</td></tr><tr><td>(<i>Biotin</i>)<i>-miD156rk</i></td><td>(Biotin)-A CGT GCT CAC TCT CTT CTG TCA</td><td>60.5</... | <table><tr><td>Names</td><td>Sequence (5′–3′)</td></tr><tr><td>Osa-miR156</td><td>UGA CAG AAG AGA GUG AGC AC</td></tr><tr><td>(Biotin)-miD156rk</td><td>(Biotin)-A CGT GCT CAC TCT CTT CTG TCA</td></tr><tr><td>(DIG)-miD156rk</td><td>(DIG)-A CGT GCT CAC TCT CTT CTG TCA</td></tr><tr><td>miD156</td><td>TGA CAG AAG AGA GTG A... | <table><tr><td>Tm (°C)</td><td>Mw</td></tr><tr><td>57.3</td><td>6279</td></tr><tr><td>60.5</td><td>6587+</td></tr><tr><td>60.5</td><td>6587+</td></tr><tr><td>57.3</td><td>6201+</td></tr><tr><td>55.4</td><td>6241</td></tr><tr><td>57.4</td><td>6242</td></tr><tr><td>59.5</td><td>6193+</td></tr><tr><td>46.1</td><td>7244</t... |
6d02c5980c337b8074aefabd60713573fa48441fba6141e2f9129dd0a7a571e9.png | simple | <table><tr><td>Test microorganisms</td><td>Inhibition zone diameter (mm) ¥</td><td>MIC (μg/ml)</td><td>MIC of penicillin (μg/ml)</td></tr><tr><td><i>Bacillus subtilis</i> MTCC 736</td><td>25 ± 1.0</td><td>2.0</td><td>0.5</td></tr><tr><td><i>Bacillus circulans</i> MTCC 8074</td><td>23 ± 1.2</td>... | <table><tr><td>Test microorganisms</td><td>Inhibition zone diameter (mm) ¥</td><td>MIC (μg/ml)</td><td>MIC of penicillin (μg/ml)</td></tr><tr><td>Bacillus subtilis MTCC 736</td><td>25 ± 1.0</td><td>2.0</td><td>0.5</td></tr><tr><td>Bacillus circulans MTCC 8074</td><td>23 ± 1.2</td><td>3.0</td><td>0.5</td></tr><tr><td>Ba... | <table><tr><td>Micrococcus luteus MTCC 2987</td><td>25 ± 1.3</td><td>2.0</td><td>0.5</td></tr><tr><td>Mycobacterium phlei MTCC 1724</td><td>25 ± 1.0</td><td>2.0</td><td>0.5</td></tr><tr><td>Mycobacterium smegmatis MTCC 6</td><td>21 ± 0.5</td><td>3.0</td><td>1.0</td></tr><tr><td>Escherichia coli MTCC 739</td><td></td><t... |
47c204c2838c69c03d047f567a0e67561e63584249cb074fcc271a3e1fd714bc.png | complex | <table><tr><td> </td><td colspan="2">6-11y (n=3,033)</td><td colspan="2">12-19y (n=5,432)</td><td colspan="2">20-50y (n=7,635)</td><td colspan="2">≥51y (n=6,752)</td><td> </td></tr><tr><td>Category<sup>1</sup></td><td>calories</td><td>% total</td><td>calories</td><td>% total</td><td>calories</td><td>% total</td><... | <table><tr><td></td><td colspan="2">6-11y (n=3,033)</td><td colspan="2">12-19y (n=5,432)</td><td colspan="2">20-50y (n=7,635)</td><td colspan="2">≥51y (n=6,752)</td><td></td></tr><tr><td>Category1</td><td>calories</td><td>% total</td><td>calories</td><td>% total</td><td>calories</td><td>% total</td><td>calories</td><td... | <table><tr><td>Sausage, franks, bacon and ribs</td><td>60</td><td>3.0</td><td>49</td><td>2.2</td><td>59</td><td>2.5</td><td>52</td><td>2.7</td><td><0.001</td></tr><tr><td>Whole milk</td><td>60</td><td>3.0</td><td>42</td><td>1.8</td><td>27</td><td>1.1</td><td>17</td><td>0.9</td><td><0.001</td></tr><tr><td>Candy</td><td>... |
c1850a45927f5864b5e17d9ee87fa456795620f166793cfa6980325ae654ce70.png | simple | <table><tr><td>Parameter</td><td>All subjects%</td><td>M%</td><td>F%</td><td>P</td></tr><tr><td>Living with one’s family</td><td>63.1</td><td>78.6</td><td>51.5</td><td><0.001**</td></tr><tr><td>Regular exercise</td><td>61.7</td><td>84.1</td><td>44.5</td><td><0.001**</td></tr><tr><td>Smokes cigarettes</td><t... | <table><tr><td>Parameter</td><td>All subjects%</td><td>M%</td><td>F%</td><td>P</td></tr><tr><td>Living with one’s family</td><td>63.1</td><td>78.6</td><td>51.5</td><td><0.001**</td></tr><tr><td>Regular exercise</td><td>61.7</td><td>84.1</td><td>44.5</td><td><0.001**</td></tr><tr><td>Smokes cigarettes</td><td>19.7</td><... | <table><tr><td>Parameter</td><td>All subjects%</td><td>M%</td><td>F%</td><td>P</td></tr><tr><td>Experienced drugs</td><td>16.4</td><td>17.0</td><td>15.9</td><td>0.01*</td></tr></table> |
6c5fd2a091a8e4ac7db53dbb1542f3740baa4d3d99e255266496b8456202818b.png | simple | <table><tr><td> </td><td>OMG</td><td>SG</td><td><i>p</i>value</td><td>OBG</td><td><i>p</i>value</td></tr><tr><td>BV/TV (%)</td><td>16.38 ± 5.69</td><td>29.47 ± 6.52*</td><td>0.001</td><td>22.39 ± 5.26*</td><td>0.005</td></tr><tr><td>Tb. Th (μm)</td><td>48.96 ± 8.64</td><td>85.36 ± 9.35*</t... | <table><tr><td></td><td>OMG</td><td>SG</td><td>pvalue</td><td>OBG</td></tr><tr><td>BV/TV (%)</td><td>16.38 ± 5.69</td><td>29.47 ± 6.52*</td><td>0.001</td><td>22.39 ± 5.26*</td></tr><tr><td>Tb. Th (μm)</td><td>48.96 ± 8.64</td><td>85.36 ± 9.35*</td><td>0.001</td><td>72.96 ± 7.37*</td></tr><tr><td>Tb. N (L/mm)</td><td>1.... | <table><tr><td>pvalue</td></tr><tr><td>0.005</td></tr><tr><td>0.002</td></tr><tr><td>0.008</td></tr><tr><td>0.008</td></tr><tr><td>0.044</td></tr><tr><td>0.039</td></tr><tr><td>-</td></tr><tr><td>0.041</td></tr><tr><td>0.001</td></tr></table> |
5560376ab999413dba5540a87bfbef5d99bcd9b5e1732c0e4ffe40caf21bfd93.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="2">Experiment 1</td><td colspan="2">Experiment 2</td></tr><tr><td>controls</td><td>db cAMP</td><td>controls</td><td>db cAMP</td></tr><tr><td colspan="5">Hypothalamus</td></tr><tr><td><i>ADCYAP1</i></td><td>0.56±0.02</td><td>0.78±0.02*</td><td>0.41±0.02... | <table><tr><td rowspan="2">Variable</td><td colspan="2">Experiment 1</td><td colspan="2">Experiment 2</td></tr><tr><td>controls</td><td>db cAMP</td><td>controls</td><td>db cAMP</td></tr><tr><td colspan="5">Hypothalamus</td></tr><tr><td>ADCYAP1</td><td>0.56±0.02</td><td>0.78±0.02*</td><td>0.41±0.02</td><td>0.59±0.02</td... | <table><tr><td>POMC#</td><td>0.49±0.02</td><td>1.13±0.01*</td><td>0.42±0.01</td><td>0.82±0.01*</td></tr><tr><td>TRHR</td><td>0.51±0.01</td><td>0.58±0.03</td><td>0.39±0.02</td><td>0.53±0.01</td></tr><tr><td>TSH</td><td>1.44±0.04</td><td>1.49±0.02</td><td>0.66±0.04</td><td>0.88±0.03</td></tr><tr><td colspan="5">Liver</td... |
53a5a560327d5433f4b6a5a8bed131a819063b0497bce64c175649f75c5929ac.png | simple | <table><tr><td></td><td>SOD (% of Control)</td><td>Catalase (% of Control)</td><td>Glutathione Reductase (% of Control)</td><td>Glucose-6-phosphate Dehydrogenase (% of Control)</td></tr><tr><td>BDP 2 μg</td><td>135 ± 2</td><td>136 ± 3</td><td>134 ± 3</td><td>132 ± 3</td></tr><tr><td>BDP 5 μ... | <table><tr><td></td><td>SOD (% of Control)</td><td>Catalase (% of Control)</td><td>Glutathione Reductase (% of Control)</td><td>Glucose-6-phosphate Dehydrogenase (% of Control)</td></tr></table> | <table><tr><td>BDP 2 μg</td><td>135 ± 2</td><td>136 ± 3</td><td>134 ± 3</td><td>132 ± 3</td></tr><tr><td>BDP 5 μg</td><td>105 ± 3</td><td>102 ± 4</td><td>103 ± 3</td><td>127 ± 4</td></tr><tr><td>BDP 10 μg</td><td>192 ± 5</td><td>204 ± 7</td><td>183 ± 2</td><td>237 ± 2</td></tr></table> |
90d074576aeaa72c6a8bf9d0531c415da446f1cf3927f8dfbe2d2aa1c8f9b1d2.png | simple | <table><tr><td>Use diversity</td><td>D. sisso</td><td>A. modesta</td><td>A. nilotica</td><td>C. desidua</td><td>M. boxifolia</td><td>Z. nummularia</td><td>M. nigra</td><td>M. azidarach</td><td>W. coagulans</td><td>R. stricta</td><td>Total</td><td>Rank</td></tr><tr><td>Construction</td><td>5</td><td>2</td><td>3</td><td>... | <table><tr><td>Use diversity</td><td>D. sisso</td><td>A. modesta</td><td>A. nilotica</td><td>C. desidua</td><td>M. boxifolia</td><td>Z. nummularia</td><td>M. nigra</td><td>M. azidarach</td><td>W. coagulans</td><td>R. stricta</td><td>Total</td><td>Rank</td></tr><tr><td>Construction</td><td>5</td><td>2</td><td>3</td><td>... | <table><tr><td>Use diversity</td><td>D. sisso</td><td>A. modesta</td><td>A. nilotica</td><td>C. desidua</td><td>M. boxifolia</td><td>Z. nummularia</td><td>M. nigra</td><td>M. azidarach</td><td>W. coagulans</td><td>R. stricta</td><td>Total</td><td>Rank</td></tr><tr><td>Firewood</td><td>3</td><td>4</td><td>3</td><td>2</t... |
6ebbe616b4664e86bc78707ad68aa20f079225b1ad06e26e6eeb18d85a4c69c0.png | complex | <table><tr><td rowspan="2">Group</td><td rowspan="2">n</td><td colspan="2">Expression of ELF</td></tr><tr><td>High</td><td>Low</td></tr><tr><td>Normal liver tissues</td><td>20</td><td>20(100.0%)</td><td>0(0.0%)</td></tr><tr><td>Adjacent tissues*</td><td>84</td><td>65(77.4%)</td><td>19(22.6%)</td></tr><tr><td>HCC tissue... | <table><tr><td rowspan="2">Group</td><td rowspan="2">n</td><td colspan="2">Expression of ELF</td></tr><tr><td>High</td><td>Low</td></tr></table> | <table><tr><td>Normal liver tissues</td><td>20</td><td>20(100.0%)</td><td>0(0.0%)</td></tr><tr><td>Adjacent tissues*</td><td>84</td><td>65(77.4%)</td><td>19(22.6%)</td></tr><tr><td>HCC tissues*#</td><td>84</td><td>40(47.6%)</td><td>44(52.4%)</td></tr></table> |
3c8cb483e8d8cce96c1982f922a50163f22511aa3f9bb4f30504645124778f67.png | complex | <table><tr><td rowspan="2">Externality category</td><td colspan="2">UK</td><td colspan="2">USA</td><td colspan="2">Germany</td></tr><tr><td>€ million</td><td>€ per kg a.i.</td><td>€ million</td><td>€ per kg a.i.</td><td>€ million</td><td>€ per kg a.i.</td></tr><tr><td>Pesticides in d... | <table><tr><td rowspan="2">Externality category</td><td colspan="2">UK</td><td colspan="2">USA</td><td colspan="2">Germany</td></tr><tr><td>€ million</td><td>€ per kg a.i.</td><td>€ million</td><td>€ per kg a.i.</td><td>€ million</td><td>€ per kg a.i.</td></tr></table> | <table><tr><td>Pesticides in drinking water</td><td>217</td><td>9.06</td><td>851</td><td>2.00</td><td>137</td><td>5.15</td></tr><tr><td>Pollution incidents, fish deaths and monitoring costs</td><td>15</td><td>0.68</td><td>122</td><td>0.29</td><td>39</td><td>1.47</td></tr><tr><td>Biodiversity and wildlife losses</td><td... |
5e830b7476ac83b729ee5dc576a7820385e70da9602c5309a8727156fd2b4bbf.png | simple | <table><tr><td></td><td>ABTS (μmol/mL)</td><td>DPPH (μmol/mL)</td><td>FRAP (mmol/mL)</td></tr><tr><td>Raw hydrolysate supernatant</td><td>5.34 ± 1.29</td><td>0.18 ± 0.08</td><td>0.60 ± 0.04</td></tr><tr><td>After ultrasound treatment</td><td>5.92 ± 0.96</td><td>0.27 ± 0.07</td><td>0.7... | <table><tr><td></td><td>ABTS (μmol/mL)</td><td>DPPH (μmol/mL)</td><td>FRAP (mmol/mL)</td></tr><tr><td>Raw hydrolysate supernatant</td><td>5.34 ± 1.29</td><td>0.18 ± 0.08</td><td>0.60 ± 0.04</td></tr><tr><td>After ultrasound treatment</td><td>5.92 ± 0.96</td><td>0.27 ± 0.07</td><td>0.73 ± 0.04</td></tr></table> | <table><tr><td>After autoclaving</td><td>7.03 ± 1.34</td><td>0.24 ± 0.05</td><td>0.79 ± 0.05</td></tr></table> |
55bd195b11158447aefad7db6e93f1b6ce7ecd4290e352ff3db09f9d23d6c23d.png | simple | <table><tr><td>ADAPT-ITT phase</td><td>Methodology</td></tr><tr><td>1. Assessment</td><td>Conducted focus groups/needs assessment with Community Advisory Board (CAB)</td></tr><tr><td>2. Decision</td><td>Decision regarding type of intervention was pre-determined by evidence base; however, decisions regarding characteris... | <table><tr><td>ADAPT-ITT phase</td><td>Methodology</td></tr><tr><td>1. Assessment</td><td>Conducted focus groups/needs assessment with Community Advisory Board (CAB)</td></tr><tr><td>2. Decision</td><td>Decision regarding type of intervention was pre-determined by evidence base; however, decisions regarding characteris... | <table><tr><td>8. Testing</td><td>A pilot test of the intervention was conducted with 10 patients to identify “hands-on” challenges requiring adaptation; a focus group was then held with 4 of those patients to further explore these challenges and solutions</td></tr></table> |
0264075355def2526025f8c633e2a65543d782831aeda5f69ba5d577bb7c3324.png | complex | <table><tr><td rowspan="2"></td><td colspan="4">MRI (+)</td><td colspan="2">MRI (−)</td><td colspan="3"><i>p</i> Value</td></tr><tr><td colspan="2">Systematic cores <i>n</i> = 2696 (A)</td><td colspan="2">Targeted cores <i>n</i> = 345 (B)</td><td colspan="2">Systematic cores <i>n</i> = 3542 (C)</td><td>A vs B</td... | <table><tr><td rowspan="2"></td><td colspan="4">MRI (+)</td><td colspan="2">MRI (−)</td><td colspan="3">p Value</td></tr><tr><td colspan="2">Systematic cores n = 2696 (A)</td><td colspan="2">Targeted cores n = 345 (B)</td><td colspan="2">Systematic cores n = 3542 (C)</td><td>A vs B</td><td>A vs C</td><td>B vs C</td></t... | <table><tr><td>Cores including GP 4 or more, n (%)</td><td>229</td><td>(8.4)</td><td>80</td><td>(23.1)</td><td>210</td><td>(5.9)</td><td><0.0001</td><td>0.0001</td><td><0.0001</td></tr><tr><td>Median percentage of core length involved by cancer (IQR)</td><td>30</td><td>(10–60)</td><td>50</td><td>(20–70)</td><td>20</td>... |
7d9aebaadb881aa4e517d55ff1889719b4863403a5402700cae5423bdf5fb8a2.png | simple | <table><tr><td></td><td>Healthy Controls (<i>n</i> = 50)</td><td>Patients (<i>n</i> = 50)</td><td><i>p</i>-Value</td></tr><tr><td>Gender female—<i>n</i> (%)</td><td>15 (30.0%)</td><td>17 (34.0%)</td><td>0.83</td></tr><tr><td>Age—median years (p 25–75)</td><td>59 (50–68)</td><td>60 (51–69)<... | <table><tr><td></td><td>Healthy Controls (n = 50)</td><td>Patients (n = 50)</td><td>p-Value</td></tr><tr><td>Gender female—n (%)</td><td>15 (30.0%)</td><td>17 (34.0%)</td><td>0.83</td></tr><tr><td>Age—median years (p 25–75)</td><td>59 (50–68)</td><td>60 (51–69)</td><td>0.47</td></tr></table> | <table><tr><td>Serum sCD154—median ng/mL (p 25–75)</td><td>0.98 (0.80–1.46)</td><td>1.79 (1.22–3.56)</td><td><0.001</td></tr></table> |
f679e38dd445c9b9520b5a0ca5ba84f44485043bcbc950372ba0edbc1ce52144.png | simple | <table><tr><td>PFT and Polygraphy (during withdrawal)</td><td><i>n</i> = 15</td></tr><tr><td>FEV1/FVC (%)</td><td>79.5 ± 7.4</td></tr><tr><td>FEV1 (%)</td><td>69.2 ± 16.4</td></tr><tr><td>FVC (%)</td><td>70.2 ± 17.3</td></tr><tr><td>AHI (n/h)</td><td>53.5 ± 26.9</td></tr><tr><td>RT < 90% (%)</td>... | <table><tr><td>PFT and Polygraphy (during withdrawal)</td><td>n = 15</td></tr><tr><td>FEV1/FVC (%)</td><td>79.5 ± 7.4</td></tr><tr><td>FEV1 (%)</td><td>69.2 ± 16.4</td></tr><tr><td>FVC (%)</td><td>70.2 ± 17.3</td></tr><tr><td>AHI (n/h)</td><td>53.5 ± 26.9</td></tr><tr><td>RT < 90% (%)</td><td>21.8 ± 24.2</td></tr></tab... | <table><tr><td>PFT and Polygraphy (during withdrawal)</td><td>n = 15</td></tr><tr><td>ODI ≥ 4% (n/h)</td><td>42.1 ± 39.5</td></tr></table> |
8f28c08723dd38a71ae6150ee0869a55139444c238239c3a3b17cd2f5653ebe7.png | simple | <table><tr><td>No.</td><td>Species</td><td>GenBank accession No.</td><td>Locality</td><td>Voucher ID</td></tr><tr><td>1</td><td><i>Cyrtodactylus badenensis</i></td><td>KF929505</td><td>Vietnam, Tay Ninh Prov.</td><td>KIZ13689</td></tr><tr><td>2</td><td><i>C. bansocensis</i></td><td>KU175573</td><td>Laos, Khammouane Pro... | <table><tr><td>No.</td><td>Species</td><td>GenBank accession No.</td><td>Locality</td><td>Voucher ID</td></tr><tr><td>1</td><td>Cyrtodactylus badenensis</td><td>KF929505</td><td>Vietnam, Tay Ninh Prov.</td><td>KIZ13689</td></tr><tr><td>2</td><td>C. bansocensis</td><td>KU175573</td><td>Laos, Khammouane Prov.</td><td>VNU... | <table><tr><td>44</td><td>C. quadrivirgatus</td><td>HM888465</td><td>Malaysia</td><td>ZMMU-RAN1989</td></tr><tr><td>45</td><td>C. quadrivirgatus</td><td>HM888466</td><td>Malaysia</td><td>ZMMU-RAN1990</td></tr><tr><td>46</td><td>C. roesleri</td><td>KF929532</td><td>Vietnam, Quang Binh Prov.</td><td>PNKB2011.34</td></tr>... |
8d3e8e32f36fde5f92b8c3a59e289c6a90207264a62644fc6e7c255e1768f8a1.png | complex | <table><tr><td><i>Clinicopathologic Characteristics</i></td><td></td></tr><tr><td colspan="2"><i>Age at diagnosis (years)</i></td></tr><tr><td> <i>Median (range)</i></td><td>62 (30–80)</td></tr><tr><td colspan="2"><i>Histology (n (%))</i></td></tr><tr><td> <i>Ductal</i></td><td>44 (90%)</td></tr><tr><td> <i>Lobul... | <table><tr><td>Clinicopathologic Characteristics</td><td></td></tr><tr><td colspan="2">Age at diagnosis (years)</td></tr><tr><td>Median (range)</td><td>62 (30–80)</td></tr><tr><td colspan="2">Histology (n (%))</td></tr><tr><td>Ductal</td><td>44 (90%)</td></tr><tr><td>Lobular</td><td>5 (10%)</td></tr><tr><td colspan="2"... | <table><tr><td>positive</td><td>8 (16%)</td></tr><tr><td>negative</td><td>41 (84%)</td></tr></table> |
aaf470ea4a62c907560ecfb4ebef0931cb8634ce746c26371adac10afa76d901.png | complex | <table><tr><td colspan="6">Univariate Analysis of log(MIF) over Time</td></tr><tr><td></td><td>Den DF</td><td><i>F</i> Value </td><td><i>P</i>-Value</td><td>Slope Estimator</td><td>SD (Estimator)</td></tr><tr><td colspan="6">Continuous variable</td></tr><tr><td>Age</td><td>47.7</td><td>0.03</td><td>0.8604</td><td>ͨ... | <table><tr><td colspan="6">Univariate Analysis of log(MIF) over Time</td></tr></table> | <table><tr><td></td><td>Den DF</td><td>F Value</td><td>P-Value</td><td>Slope Estimator</td><td>SD (Estimator)</td></tr><tr><td colspan="6">Continuous variable</td></tr><tr><td>Age</td><td>47.7</td><td>0.03</td><td>0.8604</td><td>−0.00239</td><td>0.01351</td></tr><tr><td>BMI</td><td>47.8</td><td>0.34</td><td>0.5605</td>... |
1313f725e2784f51092886823d2e949d01b149400b41c8eef24843feafee61cf.png | complex | <table><tr><td rowspan="3"></td><td colspan="4">Men/Boys</td><td colspan="4">Women/Girls</td></tr><tr><td colspan="2">Caritas population</td><td colspan="2">Barcelona residents</td><td colspan="2">Caritas population</td><td colspan="2">Barcelona residents</td></tr><tr><td>Direct Assistance Services</td><td>Housing Medi... | <table><tr><td rowspan="3"></td><td colspan="4">Men/Boys</td><td colspan="4">Women/Girls</td></tr><tr><td colspan="2">Caritas population</td><td colspan="2">Barcelona residents</td><td colspan="2">Caritas population</td><td colspan="2">Barcelona residents</td></tr><tr><td>Direct Assista</td><td>Housing Mediation</td><t... | <table><tr><td></td><td>nce Services</td><td> Service</td><td>erall</td><td>ved social classes (IV and V)</td><td>Direct Assistance Services</td><td>tion Service</td><td>rall</td><td>d V)</td></tr><tr><td>Adults</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Regular or poor sel... |
60d4493932654c6124434518290e9e39082e9c15ed3e8d0d340e68e0159bb3c9.png | simple | <table><tr><td>GENE</td><td>Sense</td><td>Anti-sense</td><td>Product</td></tr><tr><td>ABCA1</td><td>5’-AGGCCCAGACCTGTAAATGC-3’</td><td>5’-CTCACCAACCTTGCCAACTTC-3’</td><td>450 bp</td></tr><tr><td>SREBP2</td><td>5’-CAGACGCCAAGATGCACAAG-3’</td><td>5’-TGGCTCATCTTTGACCTTTGC-3’... | <table><tr><td>GENE</td><td>Sense</td><td>Anti-sense</td><td>Product</td></tr><tr><td>ABCA1</td><td>5’-AGGCCCAGACCTGTAAATGC-3’</td><td>5’-CTCACCAACCTTGCCAACTTC-3’</td><td>450 bp</td></tr><tr><td>SREBP2</td><td>5’-CAGACGCCAAGATGCACAAG-3’</td><td>5’-TGGCTCATCTTTGACCTTTGC-3’</td><td>323 bp</td></tr><tr><td>CYP7A1</td><td>... | <table><tr><td>GENE</td><td>Sense</td><td>Anti-sense</td><td>Product</td></tr><tr><td>GAPDH</td><td>5’-ACTCCTCCACCTTTGACGCTG-3’</td><td>5’-CTCTCTTCCTCTTGTGCTCTTGC-3’</td><td>182 bp</td></tr></table> |
cc20c14192693553cc876e9af53cf18e3bfb9fcdd44eb3af131a6f1c1d7d5fff.png | complex | <table><tr><td rowspan="2">District</td><td colspan="7">Percentage (%) scores of:</td></tr><tr><td>Total points</td><td>Reports</td><td>Management of supplies</td><td>Information management</td><td>Meetings</td><td>Technical support</td><td>Referrals</td></tr><tr><td>Nadowli</td><td>58.9</td><td>77.4</td><td>71.7</td><... | <table><tr><td rowspan="2">District</td><td colspan="7">Percentage (%) scores of:</td></tr><tr><td>Total points</td><td>Reports</td><td>Management of supplies</td><td>Information management</td><td>Meetings</td><td>Technical support</td><td>Referrals</td></tr><tr><td>Nadowli</td><td>58.9</td><td>77.4</td><td>71.7</td><... | <table><tr><td>Wa West</td><td>60.1</td><td>64.1</td><td>66.8</td><td>74.0</td><td>43.1</td><td>0.0</td><td>52.6</td></tr><tr><td>Lawra</td><td>30.0</td><td>46.6</td><td>30.6</td><td>28.8</td><td>26.0</td><td>12.9</td><td>35.2</td></tr></table> |
a6246d7d834288580d860748e292faef70496dfcff3e77abce6735f401687f17.png | simple | <table><tr><td>Parameter</td><td>Estimate</td><td>Std. error</td><td><i>p</i>-Value</td></tr><tr><td>Intercept</td><td>−3.96</td><td>2.90</td><td>0.18</td></tr><tr><td>Stimulation</td><td>1.46</td><td>0.74</td><td>0.05</td></tr><tr><td>Time</td><td>0.39</td><td>0.10</td><td><0.01</td></tr><tr><td>Quadrant</td>... | <table><tr><td>Parameter</td><td>Estimate</td><td>Std. error</td></tr><tr><td>Intercept</td><td>−3.96</td><td>2.90</td></tr><tr><td>Stimulation</td><td>1.46</td><td>0.74</td></tr><tr><td>Time</td><td>0.39</td><td>0.10</td></tr><tr><td>Quadrant</td><td>3.27</td><td>0.74</td></tr><tr><td>Sequence</td><td>5.99</td><td>0.9... | <table><tr><td>p-Value</td></tr><tr><td>0.18</td></tr><tr><td>0.05</td></tr><tr><td><0.01</td></tr><tr><td><0.01</td></tr><tr><td><0.01</td></tr><tr><td>0.01</td></tr><tr><td></td></tr><tr><td></td></tr></table> |
af44567ac0b03eeff603ea6b874d2ecb0f3e01c3899d60dcd239881db822f3f5.png | simple | <table><tr><td></td><td>Total</td><td>Cases</td><td>Controls</td><td><i>p<sup>a</sup></i></td></tr><tr><td>Number of participants (%)<sup>b</sup></td><td>2,042 (100)</td><td>681 (33.4)</td><td>1361 (66.7)</td><td></td></tr><tr><td>Sex (%)</td><td></td><td></td><td></td><td>0.955</td></tr><tr><td> Male</td><td>1,390 (68... | <table><tr><td></td><td>Total</td><td>Cases</td><td>Controls</td><td>pa</td></tr><tr><td>Number of participants (%)b</td><td>2,042 (100)</td><td>681 (33.4)</td><td>1361 (66.7)</td><td></td></tr><tr><td>Sex (%)</td><td></td><td></td><td></td><td>0.955</td></tr><tr><td>Male</td><td>1,390 (68.1)</td><td>463 (68.0)</td><td... | <table><tr><td>Missing</td><td>9 (0.4)</td><td>-</td><td>9 (0.7)</td><td></td></tr><tr><td>Household income (10,000 won/month)</td><td></td><td></td><td></td><td>< .001</td></tr><tr><td>< 100</td><td>176 (8.6)</td><td>91 (13.4)</td><td>85 (6.3)</td><td></td></tr><tr><td>100–200</td><td>373 (18.3)</td><td>143 (21.0)</td... |
f7db0643b1a67f4a74d23d2adbfdeab4140b464bad6c80a0c41e8adfe8b71506.png | complex | <table><tr><td colspan="5">Time I</td><td colspan="4">Time II</td></tr><tr><td>As range (μg/dL)</td><td>Freq</td><td>Freq%</td><td>CumulFreq</td><td>CumulFreq%</td><td>Freq</td><td>Freq%</td><td>CumulFreq</td><td>CumulFreq%</td></tr><tr><td>2.800–2.999</td><td>0</td><td>0.0</td><td>204</td><td>100.0</td><td>... | <table><tr><td colspan="5">Time I</td><td colspan="4">Time II</td></tr><tr><td>As range (μg/dL)</td><td>Freq</td><td>Freq%</td><td>CumulFreq</td><td>CumulFreq%</td><td>Freq</td><td>Freq%</td><td>CumulFreq</td><td>CumulFreq%</td></tr><tr><td>2.800–2.999</td><td>0</td><td>0.0</td><td>204</td><td>100.0</td><td>0</td><td>0... | <table><tr><td>800–1.999</td><td>7</td><td></td><td>200</td><td>98.0</td><td>0</td><td>0</td><td>03</td><td>99.5</td></tr><tr><td>1.600–1.799</td><td>7</td><td>3.4</td><td>193</td><td>94.6</td><td>0</td><td>0.0</td><td>203</td><td>99.5</td></tr><tr><td>1.400–1.599</td><td>14</td><td>6.9</td><td>186</td><td>91.2</td><td... |
08567b14928e412f189d4a9b25f2c5f42caecbad9b700ed454e40a555eca9e62.png | simple | <table><tr><td>Manufacturer</td><td>Name of Product</td><td>Vaccine Type</td><td>Adjuvant</td><td>Produced in</td><td>Age Recommended</td></tr><tr><td>Abbot healthcare</td><td>Trivalent: Influvac Imuvac</td><td>Inactivated</td><td>None</td><td>Egg</td><td>From 6 months</td></tr><tr><td>AstraZeneca</td><td>Quadrivalent:... | <table><tr><td>Manufacturer</td><td>Name of Product</td><td>Vaccine Type</td><td>Adjuvant</td><td>Produced in</td><td>Age Recommended</td></tr><tr><td>Abbot healthcare</td><td>Trivalent: Influvac Imuvac</td><td>Inactivated</td><td>None</td><td>Egg</td><td>From 6 months</td></tr><tr><td>AstraZeneca</td><td>Quadrivalent:... | <table><tr><td>Manufacturer</td><td>Name of Product</td><td>Vaccine Type</td><td>Adjuvant</td><td>Produced in</td><td>Age Recommended</td></tr><tr><td>GlaxoSmithKline</td><td>Quadrivalent: Fluarix Tetra Alpharix Tetra Influsplit Tetra</td><td>Inactivated/split</td><td>None</td><td>Egg</td><td>From 3 years</td></tr><tr>... |
83cf2b681da281391e654a6b22df7a1ae4a84df0aaccd95a1e5ee6b05084d3ef.png | simple | <table><tr><td>Stimuli</td><td><i>P1</i></td><td><i>N1</i></td><td><i>P2</i></td><td><i>N2</i></td><td><i>P3</i></td><td>LPP</td></tr><tr><td>FSS, RSS</td><td>100–140 ms</td><td>130–150 ms</td><td>150–220 ms</td><td>150–250 ms</td><td>250–500 ms</td><td></td></tr><tr><td>AA, RA, IA</td><td... | <table><tr><td>Stimuli</td><td>P1</td><td>N1</td><td>P2</td><td>N2</td><td>P3</td><td>LPP</td></tr></table> | <table><tr><td>FSS, RSS</td><td>100–140 ms</td><td>130–150 ms</td><td>150–220 ms</td><td>150–250 ms</td><td>250–500 ms</td><td></td></tr><tr><td>AA, RA, IA</td><td>100–180 ms</td><td>170–220 ms</td><td>190–330 ms</td><td>275–350 ms</td><td>340–590 ms</td><td>500–1000 ms</td></tr></table> |
5adb3ffa6640fad0ea8753e5847c4fa39a0e48506d2b072b249f6bdcba21e654.png | complex | <table><tr><td rowspan="2">Variable</td><td>Bacteremic</td><td>Non-bacteremic</td><td rowspan="2"><i>p</i> value</td></tr><tr><td>(<i>n</i> = 38)</td><td>(<i>n</i> = 106)</td></tr><tr><td>Age under 50 years</td><td>9 (23.7)</td><td>25 (23.6)</td><td>1.00</td></tr><tr><td>Age 50–64 years</td><td>13 (34.2)</td><td>... | <table><tr><td rowspan="2">Variable</td><td>Bacteremic</td><td>Non-bacteremic</td><td rowspan="2">p value</td></tr><tr><td>(n = 38)</td><td>(n = 106)</td></tr><tr><td>Age under 50 years</td><td>9 (23.7)</td><td>25 (23.6)</td><td>1.00</td></tr><tr><td>Age 50–64 years</td><td>13 (34.2)</td><td>31 (29.2)</td><td>0.68</td>... | <table><tr><td rowspan="2">Variable</td><td>Bacteremic</td><td>Non-bacteremic</td><td rowspan="2">p value</td></tr><tr><td>(n = 38)</td><td>(n = 106)</td></tr><tr><td>Age 65–74 years</td><td>6 (15.8)</td><td>27 (25.5)</td><td>0.27</td></tr><tr><td>Age over 75 years</td><td>10 (26.3)</td><td>23 (21.7)</td><td>0.65</td><... |
8e4dbfd1470eb3ec1efeac9e87715e15990f62bbe1c59ed03ce8171bf9352c26.png | complex | <table><tr><td>Monitoring dates</td><td colspan="4">Albendazole treated risk cattle cohort</td><td colspan="4">Placebo treated risk cattle cohort</td></tr><tr><td> </td><td>Trypanosome cases</td><td>Cattle-months</td><td>IDR</td><td>95 % CI<sup>5</sup></td><td>Trypanosome cases</td><td>Cattle-months</td><td>IDR</td><td... | <table><tr><td>Monitoring dates</td><td colspan="4">Albendazole treated risk cattle cohort</td><td colspan="4">Placebo treated risk cattle cohort</td></tr><tr><td></td><td>Trypanosome cases</td><td>Cattle-months</td><td>IDR</td><td>95 % CI5</td><td>Trypanosome cases</td><td>Cattle-months</td><td>IDR</td><td>95 % CI5</t... | <table><tr><td>Monitoring dates</td><td colspan="4">Albendazole treated risk cattle cohort</td><td colspan="4">Placebo treated risk cattle cohort</td></tr><tr><td></td><td>Trypanosome cases</td><td>Cattle-months</td><td>IDR</td><td>95 % CI5</td><td>Trypanosome cases</td><td>Cattle-months</td><td>IDR</td><td>95 % CI5</t... |
bf0eaefa3e97937dad30f08242fc7b85906288e5df0fd435676d531e866f9222.png | simple | <table><tr><td> </td><td>Method 1</td><td>Method 2</td><td>Method 3</td><td>Method 4</td><td>Method 5</td></tr><tr><td>Mean</td><td>0.20</td><td>0.10</td><td>0.10</td><td>0.23</td><td>0.45</td></tr><tr><td>SD</td><td>0.24</td><td>0.22</td><td>0.21</td><td>0.24</td><td>0.15</td></tr><tr><td>Method 1</td><td> </td><td> <... | <table><tr><td></td><td>Method 1</td><td>Method 2</td><td>Method 3</td><td>Method 4</td><td>Method 5</td></tr></table> | <table><tr><td>Mean</td><td>0.20</td><td>0.10</td><td>0.10</td><td>0.23</td><td>0.45</td></tr><tr><td>SD</td><td>0.24</td><td>0.22</td><td>0.21</td><td>0.24</td><td>0.15</td></tr><tr><td>Method 1</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Method 2</td><td>0.93</td><td></td><td></td><td></td><td></td>... |
4e4334c84aab8478e5f337b7e2923a0a80d222e874ad8395b66f47befb480de6.png | complex | <table><tr><td></td><td>% (N)</td></tr><tr><td colspan="2">Histological subtype</td></tr><tr><td> Epidermoid carcinoma</td><td>100 (392/392)</td></tr><tr><td colspan="2">Initial anatomic site</td></tr><tr><td> Glans</td><td>74.0(216/392)</td></tr><tr><td> Undetermined<sup>a</sup></td><td>15.0 (44/392)</td></tr><tr><td>... | <table><tr><td></td><td>% (N)</td></tr><tr><td colspan="2">Histological subtype</td></tr><tr><td>Epidermoid carcinoma</td><td>100 (392/392)</td></tr><tr><td colspan="2">Initial anatomic site</td></tr><tr><td>Glans</td><td>74.0(216/392)</td></tr><tr><td>Undetermineda</td><td>15.0 (44/392)</td></tr><tr><td>Foreskin</td><... | <table><tr><td></td><td>% (N)</td></tr><tr><td>Stage 4</td><td>2.2 (8/366)</td></tr></table> |
8eb9a821eba2ca39ee7988c8b764c7a121665b757e36185f14c80e5dd70a715c.png | complex | <table><tr><td>Study</td><td>Measure</td><td>Assessed variable</td><td>Time of assessment</td></tr><tr><td>Study 1 cultural validity</td><td>Cultural Relevance Questionnaire (CRQ)</td><td>Culturally adapted internet-delivered treatment</td><td>Completed by experts and users before the trial.</td></tr><tr><td rowspan="5... | <table><tr><td>Study</td><td>Measure</td><td>Assessed variable</td><td>Time of assessment</td></tr><tr><td>Study 1 cultu</td><td>Cultural R</td><td>Culturally ada</td><td>Complet</td></tr></table> | <table><tr><td>Study</td><td>Measure</td><td>Assessed variable</td><td>Time of assessment</td></tr><tr><td>ral validity</td><td>elevance Questionnaire (CRQ)</td><td>pted internet-delivered treatment</td><td>ed by experts and users before the trial.</td></tr><tr><td rowspan="5">Study 2 efficacy trial</td><td>Patient Hea... |
c82df6135a76ba28de2644f83dc4af6e166c1e663617f6c431b5b9d501c4fb29.png | simple | <table><tr><td>Author, date</td><td>Conclusions</td><td>Contributions</td></tr><tr><td>Levy et al., 2009 [1]</td><td>AUT is not a monogenic disorder, in many individuals may be the result of a complex amalgam of multiple simultaneous genetic variations, and present morphological and functional brain abnormalities.</td>... | <table><tr><td>Author, date</td><td>Conclusions</td></tr><tr><td>Levy et al., 2009 [1]</td><td>AUT is not a monogenic disorder, in many individuals may be the result of a complex amalgam of multiple simultaneous genetic variations, and present morphological and functional brain abnormalities.</td></tr><tr><td>Baron-Coh... | <table><tr><td>Contributions</td></tr><tr><td>Highlights the importance of understanding biological markers, patterns of cortical organization and connectivity in advancing the treatment of AUT.</td></tr><tr><td>Highlights the role of the amygdala in the symptoms of ASD.</td></tr><tr><td>Relates the difficulties in und... |
e134c2b4c5e80ad103830c67e02ff61fad77f105749180fb3e4da05d92e83c46.png | simple | <table><tr><td><i>Manufacturer</i></td><td><i>Diameter (mm)</i></td><td><i>Mean Life</i></td><td><i>St. Dev</i></td></tr><tr><td>Ace</td><td>4.5</td><td>10115</td><td>4426</td></tr><tr><td>Biomet</td><td>4.0</td><td>1502</td><td>615</td></tr><tr><td></td><td>5.0</td><td>360881</td><td>469213</td></tr><tr><td>Synthes</t... | <table><tr><td>Manufacturer</td><td>Diameter (mm)</td><td>Mean Life</td><td>St. Dev</td></tr><tr><td>Ace</td><td>4.5</td><td>10115</td><td>4426</td></tr><tr><td>Biomet</td><td>4.0</td><td>1502</td><td>615</td></tr><tr><td></td><td>5.0</td><td>360881</td><td>469213</td></tr><tr><td>Synthes</td><td>3.9</td><td>1413</td><... | <table><tr><td>Manufacturer</td><td>Diameter (mm)</td><td>Mean Life</td><td>St. Dev</td></tr><tr><td></td><td>.0</td><td>736</td><td>02</td></tr><tr><td>S&N – Trigen</td><td>5.0</td><td>436248</td><td>487507</td></tr></table> |
fc0cee67fd38f859dae03dcd8c22c91a028be1f537605e67aeae3adf07c05070.png | simple | <table><tr><td>Study</td><td>Parameter estimate</td><td>Standard error</td><td>Weight in fixed effects model</td><td>Weight in random effects model</td></tr><tr><td>ACT</td><td>−0.01220</td><td>0.01223</td><td>0.03788</td><td>0.11078</td></tr><tr><td>LRC</td><td>0.01437</td><td>0.01063</td><td>0.05015</td><td>0.1... | <table><tr><td>Study</td><td>Parameter estimate</td><td>Standard error</td><td>Weight in fixed effects model</td><td>Weight in random effects model</td></tr><tr><td>ACT</td><td>−0.01220</td><td>0.01223</td><td>0.03788</td><td>0.11078</td></tr><tr><td>LRC</td><td>0.01437</td><td>0.01063</td><td>0.05015</td><td>0.11780</... | <table><tr><td>DISC</td><td>0.18181</td><td>0.25408</td><td>0.00009</td><td>0.00105</td></tr><tr><td>DPP</td><td>−0.02086</td><td>0.00964</td><td>0.06098</td><td>0.12205</td></tr><tr><td>MRFIT</td><td>0.00043</td><td>0.00608</td><td>0.15329</td><td>0.13568</td></tr><tr><td>PREMIER</td><td>−0.01004</td><td>0.01002</td><... |
a2478cce2a95d5661516a22750d5d84e474b7416426b2e7dddfec500af78e214.png | complex | <table><tr><td rowspan="2">Outcome</td><td colspan="2">Per 10 μg/m<sup>3</sup> PM<sub>2.5</sub> exposure</td><td colspan="2">Per 10 ppb NO<sub>2</sub> exposure</td></tr><tr><td>mmHg (95% CI)</td><td><i>p</i>-Value</td><td>mmHg (95% CI)</td><td><i>p</i>-Value</td></tr><tr><td>Systolic blood pressure</td></tr><tr><t... | <table><tr><td rowspan="2">Outcome</td><td colspan="2">Per 10 μg/m3 PM2.5 exposure</td><td colspan="2">Per 10 ppb NO2 exposure</td></tr><tr><td>mmHg (95% CI)</td><td>p-Value</td><td>mmHg (95% CI)</td><td>p-Value</td></tr><tr><td>Systolic blood pressure</td><td colspan="4"></td></tr><tr><td>Model 1</td><td>0.8 (0.3, 1.3... | <table><tr><td rowspan="2">Outcome</td><td colspan="2">Per 10 μg/m3 PM2.5 exposure</td><td colspan="2">Per 10 ppb NO2 exposure</td></tr><tr><td>mmHg (95% CI)</td><td>p-Value</td><td>mmHg (95% CI)</td><td>p-Value</td></tr><tr><td>Model 3</td><td>1.9 (1.0, 2.8)</td><td>< 0.001</td><td>0.3 (0.0, 0.6)</td><td>0.07</td></tr... |
4f90cde2798352f9850700d626ce3401ec07bc69d9b00ae45fc4c0ffcb12d6e0.png | complex | <table><tr><td><i>Data collection</i></td><td><i>Measurement tool</i></td><td><i>Data collected method</i></td><td><i>Timeframe</i></td></tr><tr><td rowspan="2"><i>Measurement of total ulcer area</i></td><td><i>Centimetres squared;</i></td><td rowspan="2"><i>Research assistant</i></td><td rowspan="2"><i>Weekly: Post-tr... | <table><tr><td>Data collection</td><td>Measurement tool</td><td>Data collected method</td><td>Timeframe</td></tr><tr><td rowspan="2">Measurement of total ulcer area</td><td>Centimetres squared;</td><td rowspan="2">Research assistant</td><td rowspan="2">Weekly: Post-treatment until healed or at 6 months</td></tr><tr><td... | <table><tr><td>Royal District Nursing Service for ulcer management</td><td>Frequency and cost of service</td><td>Participant interview</td><td>Monthly until healed or at 6 months</td></tr><tr><td>Ongoing ulcer care products</td><td>Valued using market prices</td><td>Participant interview</td><td>Monthly until healed or... |
b43dd7f555cee5d5fc4a012fe4cca9c61b26dc3566838416e03f232abc816915.png | simple | <table><tr><td>RI of interest</td><td>Tc-99m</td><td></td><td></td><td>I-123</td><td></td><td></td></tr><tr><td>Acquisition (photopeak count ratio)</td><td>None</td><td>FiveEW-woDR</td><td>FiveEW</td><td>None</td><td>FiveEW-woDR</td><td>FiveEW</td></tr><tr><td>Single (%)</td><td>25.6</td><td>4.1</td><td>2.4</td><td>14.... | <table><tr><td>RI of interest</td><td>Tc-99m</td><td></td><td></td><td>I-123</td><td></td><td></td></tr><tr><td>Acquisition (photopeak count ratio)</td><td>None</td><td>FiveEW-woDR</td><td>FiveEW</td><td>None</td><td>FiveEW-woDR</td><td>FiveEW</td></tr><tr><td>Single (%)</td><td>25.6</td><td>4.1</td><td>2.4</td><td>14.... | <table><tr><td>RI of interest</td><td>Tc-99m</td><td></td><td></td><td>I-123</td><td></td><td></td></tr><tr><td>7) (%)</td><td>200.5</td><td>.0</td><td>0</td><td></td><td>.6</td><td></td></tr><tr><td>Dual (Tc:I = 4:6) (%)</td><td>138.1</td><td>1.1</td><td>7.9</td><td>14.3</td><td>72.6</td><td>40.0</td></tr><tr><td>Dual... |
459fe837ca75064b579fda70549eee69b7480b91d75e6941033589d431a55af7.png | simple | <table><tr><td>6MWD (m)</td><td>Overall</td><td>GROC < 2</td><td>GROC ≥ 2</td><td><i>P </i>value</td></tr><tr><td>Pre-intervention</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Mean (SD)</td><td>294.7 (78.4)</td><td>269.2 (93.9)</td><td>297.0 (77.3)</td><td>0.41</td></tr><tr><td>Post-intervention</t... | <table><tr><td>6MWD (m)</td><td>Overall</td><td>GROC < 2</td><td>GROC ≥ 2</td><td>P value</td></tr><tr><td>Pre-intervention</td><td></td><td></td><td></td><td></td></tr><tr><td>Mean (SD)</td><td>294.7 (78.4)</td><td>269.2 (93.9)</td><td>297.0 (77.3)</td><td>0.41</td></tr><tr><td>Post-intervention</td><td></td><td></td>... | <table><tr><td>Mean (SD)</td><td>330.0 (77.6)</td><td>278.4 (91.9)</td><td>334.3 (75.3)</td><td>0.091</td></tr><tr><td>Change from baseline</td><td></td><td></td><td></td><td></td></tr><tr><td>Mean (SD)</td><td>35.0 (45.2) *</td><td>9.3 (18.2)</td><td>37.3 (46.2)</td><td>0.011 †</td></tr></table> |
ae44977bf54ce0f848a585d3ac7a9300004a227e4ebac450a76d3796f7f4cc96.png | simple | <table><tr><td>Explanatory variable</td><td><i>d.f.</i></td><td>Mean square</td><td><i>F</i>-value</td><td><i>P</i></td></tr><tr><td>TREATMENT</td><td>2</td><td>0.4168</td><td>5.08</td><td>0.0302</td></tr><tr><td>LARVAE</td><td>1</td><td>0.2237</td><td>3.44</td><td>0.0670</td></tr><tr><td>TREATMENT (DAY)</td><td>9</td>... | <table><tr><td>Explanatory variable</td><td>d.f.</td><td>Mean square</td><td>F-value</td><td>P</td></tr></table> | <table><tr><td>TREATMENT</td><td>2</td><td>0.4168</td><td>5.08</td><td>0.0302</td></tr><tr><td>LARVAE</td><td>1</td><td>0.2237</td><td>3.44</td><td>0.0670</td></tr><tr><td>TREATMENT (DAY)</td><td>9</td><td>0.0831</td><td>1.28</td><td>0.2603</td></tr><tr><td>Error</td><td>92</td><td>0.0651</td><td></td><td></td></tr></t... |
c800c337893951d4df94edb3fdd8fd35c30e88b357d08ab0f3fc7f5764da7aef.png | simple | <table><tr><td>Variable (units)</td><td>Men</td><td>Women</td><td><i>P</i> value</td></tr><tr><td>N</td><td>141</td><td>16</td><td>-</td></tr><tr><td>Age (y)</td><td>41.9 ± 9.7</td><td>42.0 ± 6.1</td><td>0.98</td></tr><tr><td>Body mass (kg)</td><td>75.0 ± 9.2</td><td>56.6 ± 7.1</td><td><0.01</td>... | <table><tr><td>Variable (units)</td><td>Men</td><td>Women</td><td>P value</td></tr><tr><td>N</td><td>141</td><td>16</td><td>-</td></tr><tr><td>Age (y)</td><td>41.9 ± 9.7</td><td>42.0 ± 6.1</td><td>0.98</td></tr><tr><td>Body mass (kg)</td><td>75.0 ± 9.2</td><td>56.6 ± 7.1</td><td><0.01</td></tr><tr><td>Body surface area... | <table><tr><td>Running experience (yr)</td><td>10.7 ± 9.8</td><td>9.5 ± 5.9</td><td>0.67</td></tr><tr><td>Completed marathons (number)</td><td>7 ± 3</td><td>5 ± 2</td><td>0.42</td></tr><tr><td>Average training distance · week−1 (km)</td><td>62.7 ± 27.8</td><td>59.5 ± 26.6</td><td>0.69</td></tr><tr><td>Training sessions... |
1984ca90a11435591b8b8f9897905a0dddce601c1449e7c0e99cb71e3a287c9f.png | simple | <table><tr><td>Murine models of infection</td><td>Immune outcome</td><td>Reference</td></tr><tr><td>FrCasE virus (MLV)</td><td>Enhanced memory cellular CD8+ responses</td><td><sup>43</sup></td></tr><tr><td>Influenza</td><td>Prolonged Ag presentation by DC; enhanced proliferation of CD8+ T cells</td><td><sup>64</sup></t... | <table><tr><td>Murine models of infection</td><td>Immune outcome</td></tr><tr><td>FrCasE virus (MLV)</td><td>Enhanced memory cellular CD8+ responses</td></tr><tr><td>Influenza</td><td>Prolonged Ag presentation by DC; enhanced proliferation of CD8+ T cells</td></tr><tr><td>RSV</td><td>Modification of CD4+/CD8+ T-cell ba... | <table><tr><td>Reference</td></tr><tr><td>43</td></tr><tr><td>64</td></tr><tr><td>65</td></tr><tr><td>66</td></tr></table> |
6649ed5f10f28514d7a35c5ac4a81c4b656aff95822fe5ab7c444d9393900b5a.png | complex | <table><tr><td>N test group=23N control group=23</td><td>Baseline</td><td>3 months</td><td>6 months</td><td>Difference t0-t3</td><td>Difference t0-t6</td></tr><tr><td colspan="6">BoP (%)</td></tr><tr><td>TestControl</td><td>17.0 (13.0, 19.0) ***16.0 (13.0, 19.0) ***</td><td>6.0 (4.0, 9.0) *** ††9.0 (5.0, 12... | <table><tr><td>N test group=23N control group=23</td><td>Baseline</td><td>3 months</td><td>6 months</td></tr><tr><td colspan="4">BoP (%)</td></tr><tr><td>TestControl</td><td>17.0 (13.0, 19.0) ***16.0 (13.0, 19.0) ***</td><td>6.0 (4.0, 9.0) *** ††9.0 (5.0, 12.0) ***</td><td>12.0 (9.0, 14.0) ***11.0 (8.0, 17.0) ***</td><... | <table><tr><td>Difference t0-t3</td><td>Difference t0-t6</td></tr><tr><td colspan="2">BoP (%)</td></tr><tr><td>10.0 (8.0, 12.0) *** †9.0 (6.0, 11.0) ***</td><td>5.0 (3.0, 8.0) ***4.0 (2.0, 7.0) ***</td></tr><tr><td>10.3 ± 3.18.0 ± 4.0</td><td>5.0 ± 4.03.7 ± 5.6</td></tr><tr><td colspan="2">SBI (%)</td></tr><tr><td>7.0 ... |
e81e51086e51987d098b2ae83650ce85dd42abef966cdf1123e391cdefc7bbe5.png | complex | <table><tr><td></td><td colspan="4">Fungi</td><td colspan="4">Bacteria</td></tr><tr><td></td><td colspan="2">Endorhiza</td><td colspan="2">Rhizosphere</td><td colspan="2">Endorhiza</td><td colspan="2">Rhizosphere</td></tr><tr><td></td><td><i>P</i></td><td><i>D</i></td><td><i>P</i></td><td><i>D</i></td><td><i>P</i></td>... | <table><tr><td></td><td colspan="4">Fungi</td><td colspan="4">Bacteria</td></tr><tr><td></td><td colspan="2">Endorhiza</td><td colspan="2">Rhizosphere</td><td colspan="2">Endorhiza</td><td colspan="2">Rhizosphere</td></tr><tr><td></td><td>P</td><td>D</td><td>P</td><td>D</td><td>P</td><td>D</td><td>P</td><td>D</td></tr>... | <table><tr><td>C/W</td><td>0.3</td><td>0.8</td><td>0.5</td><td>0.3</td><td>0.03</td><td>8.2</td><td>0.03</td><td>7.8</td></tr><tr><td>C/G</td><td>0.03</td><td>8.7</td><td>0.06</td><td>2.9</td><td>0.03</td><td>5.2</td><td>0.03</td><td>7.1</td></tr><tr><td>C/GW</td><td>0.03</td><td>12.4</td><td>0.17</td><td>1.2</td><td>0... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.